{"content":"<li class=\"n-box-item date-title\" data-end=\"1553831999\" data-start=\"1553745600\" data-txt=\"Monday, December 23, 2019\">Thursday, March 28, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3446723\" data-ts=\"1553811192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446723-vtv-therapeuticsplus-8_9-on-plans-for-alzheimers-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VTv Therapeutics +8.9% on plans for Alzheimer&#39;s presentation</a></h4><ul>   <li>VTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics Inc.'>VTVT</a>) is <font color=\"green\">8.9% higher</font> after hours following its announcement that it will <a href=\"https://seekingalpha.com/pr/17459169-vtv-therapeutics-present-14th-international-conference-alzheimer-s-and-parkinson-s-diseases\" target=\"_blank\">present results</a> at the 14th International Conference on Alzheimer\u2019s &amp; Parkinson\u2019s Diseases in Portugal, which runs through Monday.</li>    <li>The company will describe results from the STEADFAST study for a subgroup of patients with mild Alzheimer's disease and type 2 diabetes.</li>    <li>Those results support the hypothesis that treatment with azeliragon may improve cognition and/or preserve function in those patients.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446723\" data-linked=\"VTv Therapeutics +8.9% on plans for Alzheimer&#39;s presentation\" data-tweet=\"$VTVT - VTv Therapeutics +8.9% on plans for Alzheimer&#39;s presentation https://seekingalpha.com/news/3446723-vtv-therapeuticsplus-8_9-on-plans-for-alzheimers-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3446723-vtv-therapeuticsplus-8_9-on-plans-for-alzheimers-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446722\" data-ts=\"1553810881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446722-chicken-soup-for-soul-jumps-on-crackle-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chicken Soup for the Soul jumps on Crackle deal</a></h4><ul>   <li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CSSE' title='Chicken Soup for the Soul Entertainment, Inc.'>CSSE</a>) is <font color=\"green\">up 13.6%</font> after hours following news that it's buying a majority of Sony's (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>) <a href=\"https://www.thewrap.com/members/2019/03/28/sony-sells-majority-stake-of-crackle-to-chicken-soup-for-the-soul/\" target=\"_blank\">stake in Crackle</a>.</li>    <li>The two companies will establish a streaming joint venture, Crackle Plus, that is expected to include CSSE's six ad-supported video on demand networks (including Popcornflix, Truli, Frightpix and Espanolflix) as well as subscription VOD site Pivotshare.</li>    <li>That venture would have a combined audience of 10M monthly active users, along with 38,500 hours of programming.</li>    <li>CSSE would own a majority interest in the JV, while Sony will get 4M five-year warrants to buy CSSE stock.</li>    <li><a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a> is <font color=\"red\">0.2% lower</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446722\" data-linked=\"Chicken Soup for the Soul jumps on Crackle deal\" data-tweet=\"$CSSE $SNE - Chicken Soup for the Soul jumps on Crackle deal https://seekingalpha.com/news/3446722-chicken-soup-for-soul-jumps-on-crackle-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3446722-chicken-soup-for-soul-jumps-on-crackle-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446715\" data-ts=\"1553809512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446715-vjet-rh-saic-and-spi-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VJET, RH, SAIC and SPI among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a> <font color=\"green\">+24.1%</font>. <a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a> <font color=\"green\">+8.2%</font>. <a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color=\"green\">+6.9%</font>. <a href='https://seekingalpha.com/symbol/EXP' title='Eagle Materials Inc.'>EXP</a> <font color=\"green\">+6.8%</font>. <a href='https://seekingalpha.com/symbol/ARVN' title='Arvinas, Inc.'>ARVN</a> <font color=\"green\">+4.7%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a> <font color=\"red\">-16%</font>. <a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a> <font color=\"red\">-12.8%</font>. <a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color=\"red\">-12.1%</font>. <a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries, Inc.'>OXM</a> <font color=\"red\">-9.3%</font>. <a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color=\"red\">-6.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446715\" data-linked=\"VJET, RH, SAIC and SPI among notable after hour movers\" data-tweet=\"$PRGS $VJET $SAIC - VJET, RH, SAIC and SPI among notable after hour movers https://seekingalpha.com/news/3446715-vjet-rh-saic-and-spi-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446715-vjet-rh-saic-and-spi-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446712\" data-ts=\"1553809009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REV\" target=\"_blank\">REV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446712-revlonminus-2-after-warning-on-material-weakness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revlon -2% after warning on material weakness</a></h4><ul> <li>Revlon (NYSE:<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a>) is <font color=\"red\">down 2.0%</font> in AH trading after disclosing that it identified a material weakness in its internal control over financial reporting primarily related to the implementation of the company\u2019s new ERP system.</li> <li>Due to the issue, the company concluded that its internal control over financial reporting was not effective.</li> <li><a href=\"https://seekingalpha.com/filing/4422705\" target=\"_blank\">SEC Form 10-K</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3446712\" data-linked=\"Revlon -2% after warning on material weakness\" data-tweet=\"$REV - Revlon -2% after warning on material weakness https://seekingalpha.com/news/3446712-revlonminus-2-after-warning-on-material-weakness?source=tweet\" data-url=\"https://seekingalpha.com/news/3446712-revlonminus-2-after-warning-on-material-weakness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446710\" data-ts=\"1553808460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REED\" target=\"_blank\">REED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446710-reedsplus-4-after-narrowing-operating-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reed&#39;s +4% after narrowing operating loss</a></h4><ul> <li>Reed's (NYSEMKT:<a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a>) reports core brand gross sales were up 10% in <a href=\"https://seekingalpha.com/pr/17459086-reed-s-inc-announces-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4</a>, driven by a 33% gain for the Virgil brand.</li> <li>Gross profit rose 29% Y/Y to $2.9M to rep 28% of sales vs. 21% a year ago.</li> <li>The company narrowed its operating loss to $2.1M from $6.1M last year.</li> <li>Management update: \"We anticipate accelerated growth for the Reed\u2019s brand and forecast 20% to 30% growth of our core brands during 2019. We generated a nearly 1,000 basis point increase in our gross margins during 2018 and anticipate further improvement as 2019 progresses as we capture scale efficiencies in cans and the elimination of idle plant costs as we have exited our Los Angeles production facility. As a result of our very successful recent follow-on offering, where we raised $16.2 million of gross proceeds, we are well capitalized to support our growth initiatives.\"</li> <li>REED <font color=\"green\">+4.25%</font> AH.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446635-reeds-misses-0_01-misses-revenue\" target=\"_blank\">Reed's misses by $0.01, misses on revenue</a> (March 28)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446710\" data-linked=\"Reed&#39;s +4% after narrowing operating loss\" data-tweet=\"$REED - Reed&#39;s +4% after narrowing operating loss https://seekingalpha.com/news/3446710-reedsplus-4-after-narrowing-operating-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3446710-reedsplus-4-after-narrowing-operating-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446707\" data-ts=\"1553807888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446707-advent-reduces-stake-in-lululemon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advent reduces its stake in Lululemon</a></h4><ul><li>Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) agrees<a href=\"https://seekingalpha.com/pr/17459220-lululemon-athletica-inc-announces-repurchase-one-million-shares-advent-international\" target=\"_blank\"> to buy back</a> 1M shares of its common stock from funds affiliated with Advent International.</li><li>Advent also informed Lululemon that it sold an additional 4M shares. That will reduce Advent's holdings, previously ~10.1M shares, by almost half.</li><li>Lululemon will fund the stock buyback with cash and will have $337M remaining under its $500M share repurchase authorization.</li><li>LULU falls 1.2% in after-hours trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446480-lululemon-bid-time-high\" target=\"_blank\">Lululemon bid up to all-time high</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446707\" data-linked=\"Advent reduces its stake in Lululemon\" data-tweet=\"$LULU - Advent reduces its stake in Lululemon https://seekingalpha.com/news/3446707-advent-reduces-stake-in-lululemon?source=tweet\" data-url=\"https://seekingalpha.com/news/3446707-advent-reduces-stake-in-lululemon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446699\" data-ts=\"1553807203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXP\" target=\"_blank\">EXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446699-eagle-materialsplus-6-after-sachem-fund-reports-8_9-active-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eagle Materials +6% after Sachem fund reports 8.9% active stake</a></h4><ul><li>Eagle Materials (NYSE:<a href='https://seekingalpha.com/symbol/EXP' title='Eagle Materials Inc.'>EXP</a>) <font color=\"green\">+6%</font> after-hours as Sachem Head Capital Management <a href=\"https://www.sec.gov/Archives/edgar/data/918646/000091412119000695/sa53515940-sc13d.htm\" target=\"_blank\">discloses an 8.9% active stake</a> in the company and says it intends to engage in discussions with EXP's management and board \"on issues that may relate to the business.\"</li><li>Sachem says it believes EXP is undervalued but wants the company to <a href=\"https://finance.yahoo.com/news/sachem-head-push-breakup-eagle-200115318.html\" target=\"_blank\">consider divesting its frac sand business</a>, which it says has depressed the stock price in recent years.</li><li>Sachem also thinks EXP could return capital to shareholders through a share buyback, as it has relatively little debt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446699\" data-linked=\"Eagle Materials +6% after Sachem fund reports 8.9% active stake\" data-tweet=\"$EXP - Eagle Materials +6% after Sachem fund reports 8.9% active stake https://seekingalpha.com/news/3446699-eagle-materialsplus-6-after-sachem-fund-reports-8_9-active-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3446699-eagle-materialsplus-6-after-sachem-fund-reports-8_9-active-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446694\" data-ts=\"1553807010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446694-amarin-files-u-s-application-for-expanded-label-for-vascepa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin files U.S. application for expanded label for Vascepa</a></h4><ul><li>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) has filed a <a href=\"https://seekingalpha.com/pr/17459215-amarin-submits-supplemental-new-drug-application-snda-u-s-fda-seeking-new-indication-vascepa\" target=\"_blank\">supplemental marketing application</a> with the FDA seeking a cardiovascular &#40;CV&#41; benefit claim for Vascepa (icosapent ethyl) based on the results from the large-scale <a href=\"https://clinicaltrials.gov/ct2/show/NCT01492361?term=reduce-it&amp;rank=1\" target=\"_blank\">REDUCE-IT</a> trial.</li><li>Assuming the standard 10-month review cycle, the agency's action date (provided that it accepts the application in a timely manner) should be in Q1 2020.</li><li>Shares are up a fraction after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446694\" data-linked=\"Amarin files U.S. application for expanded label for Vascepa\" data-tweet=\"$AMRN - Amarin files U.S. application for expanded label for Vascepa https://seekingalpha.com/news/3446694-amarin-files-u-s-application-for-expanded-label-for-vascepa?source=tweet\" data-url=\"https://seekingalpha.com/news/3446694-amarin-files-u-s-application-for-expanded-label-for-vascepa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>97&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446689\" data-ts=\"1553806536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446689-rh-scales-back-year-guidance-shares-slump-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH scales back year guidance; shares slump 17%</a></h4><ul><li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) <font color=\"red\">sinks 17%</font> in after-hours trading it trims its<a href=\"https://seekingalpha.com/pr/17459160-rh-reports-record-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\"> FY2019 guidance</a> due to \"market volatility and negative trends in high-end housing,\" moves to cut unprofitable and non-strategic businesses, and other actions to improve profitability.</li><li>Sees FY 2019 net revenue of $2.585B-$2.635B; consensus estimate of $2.75B; had seen $2.72B-$2.82B range.</li><li>Trims FY2019 adjusted operating margin guidance to 12.7%-13.3% from 13.0%-14.0%.</li><li>Sees FY2019 adjusted EPS of $8.41-$9.08; consensus estimate of $9.98.</li><li>Plans to open 5 new galleries in H2 FY2019; delays opening of New York Guesthouse to spring of 2020 due to continued construction in the area.</li><li>Reiterates long-term targets.</li><li><a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.rh.com&amp;esheet=51961165&amp;newsitemid=20190328005931&amp;lan=en-US&amp;anchor=ir.rh.com&amp;index=1&amp;md5=bcc273745c5d52ef9270f5edfe0a04b6\" target=\"_blank\">Conference call</a> at 5:00 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446665-rh-beats-0_14-misses-revenue\" target=\"_blank\">RH beats by $0.14, misses on revenue</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446689\" data-linked=\"RH scales back year guidance; shares slump 17%\" data-tweet=\"$RH - RH scales back year guidance; shares slump 17% https://seekingalpha.com/news/3446689-rh-scales-back-year-guidance-shares-slump-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3446689-rh-scales-back-year-guidance-shares-slump-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446682\" data-ts=\"1553805714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGS\" target=\"_blank\">PRGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446682-progress-softwareplus-20-on-beats-upside-fy-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress Software +20% on beats, upside FY outlook</a></h4><ul><li>Progress Software (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a>) <font color=\"green\">gains 20%</font> on Q1 beats and a Q2 outlook that has upside revenue from $96M to $99M (consensus: $93.22M) and EPS from $0.55 to $0.57 (consensus: $0.57).</li><li>Upside FY19 guidance has revenue from $422M to $428M (consensus: $383.42M) and EPS of $2.46 to $2.52 (consensus: $2.37).</li><li>Acquisition: Progress announces acquiring network management company Ipswitch for $225M in cash. Progress expects the buy to contribute significantly to non-GAAP revenue, profitability, and cash flow in FY19. Deal is expected to close in April.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://www.progress.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17459138-progress-reports-2019-fiscal-first-quarter-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446669-progress-software-beats-0_03-beats-revenue\" target=\"_blank\">Progress Software beats by $0.03, beats on revenue</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446682\" data-linked=\"Progress Software +20% on beats, upside FY outlook\" data-tweet=\"$PRGS - Progress Software +20% on beats, upside FY outlook https://seekingalpha.com/news/3446682-progress-softwareplus-20-on-beats-upside-fy-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3446682-progress-softwareplus-20-on-beats-upside-fy-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446669\" data-ts=\"1553804847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGS\" target=\"_blank\">PRGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446669-progress-software-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress Software beats by $0.03, beats on revenue</a></h4><ul><li>Progress Software (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a>): Q1 Non-GAAP EPS of $0.50 <span style=\"color:green\">beats by $0.03</span>; GAAP EPS of $0.21.</li><li>Revenue of $89.55M (-6.1% Y/Y) <font color=\"green\">beats by $1.91M</font>.</li><li>Shares <font color=\"green\">+15%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17459138-progress-reports-2019-fiscal-first-quarter-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446669\" data-linked=\"Progress Software beats by $0.03, beats on revenue\" data-tweet=\"$PRGS - Progress Software beats by $0.03, beats on revenue https://seekingalpha.com/news/3446669-progress-software-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3446669-progress-software-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446658\" data-ts=\"1553804468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVAX\" target=\"_blank\">DVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446658-dynavax-heplisav-b-marketing-application-accepted-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynavax Heplisav-B marketing application accepted in Europe</a></h4><ul><li>The European Medicines Agency has <a href=\"https://seekingalpha.com/pr/17459088-dynavax-announces-european-medicines-agency-accepts-marketing-authorization-application\" target=\"_blank\">accepted for review</a> Dynavax Technologies' (NASDAQ:<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>) marketing application seeking approval for HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for the prevention of infection caused by all known subtypes of hepatitis B virus &#40;HBV&#41; in adults at least 18 years old.</li><li>The EMA should announce its decision in 2020.</li><li>Shares are down <font color=\"red\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446658\" data-linked=\"Dynavax Heplisav-B marketing application accepted in Europe\" data-tweet=\"$DVAX - Dynavax Heplisav-B marketing application accepted in Europe https://seekingalpha.com/news/3446658-dynavax-heplisav-b-marketing-application-accepted-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3446658-dynavax-heplisav-b-marketing-application-accepted-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446654\" data-ts=\"1553804271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGH\" target=\"_blank\">SGH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446654-smart-globalminus-13_5-on-weak-eps-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SMART Global -13.5% on weak EPS forecast</a></h4><ul><li>SMART Global Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a>) <font color=\"red\">plunges 13.5%</font> after Q2 results beat EPS estimates but missed on revenue. Downside Q3 guidance has revenue from $260M to $270M (consensus: $334.36) and EPS from $0.34 to $0.38 (consensus: $0.90).</li><li>Earnings call is scheduled for 4:30 PM ET with a webcast available <a href=\"http://ir.smartgh.com/phoenix.zhtml?c=254539&amp;p=irol-irhome\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17459095-smart-global-holdings-reports-second-quarter-fiscal-2019-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446633-smart-global-beats-0_02-misses-revenue\" target=\"_blank\">SMART Global beats by $0.02, misses on revenue</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446654\" data-linked=\"SMART Global -13.5% on weak EPS forecast\" data-tweet=\"$SGH - SMART Global -13.5% on weak EPS forecast https://seekingalpha.com/news/3446654-smart-globalminus-13_5-on-weak-eps-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3446654-smart-globalminus-13_5-on-weak-eps-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446648\" data-ts=\"1553804196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446648-science-applications-beats-0_31-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Science Applications beats by $0.31, beats on revenue</a></h4><ul><li>Science Applications (NYSE:<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a>): Q4 Non-GAAP EPS of $1.17 <span style=\"color:green\">beats by $0.31</span>; GAAP EPS of -$0.20.</li><li>Revenue of $1.19B (+0.8% Y/Y) <font color=\"green\">beats by $20M</font>.</li><li>Shares <font color=\"green\">+3.1%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17459119-saic-announces-fourth-quarter-full-fiscal-year-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446648\" data-linked=\"Science Applications beats by $0.31, beats on revenue\" data-tweet=\"$SAIC - Science Applications beats by $0.31, beats on revenue https://seekingalpha.com/news/3446648-science-applications-beats-0_31-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3446648-science-applications-beats-0_31-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446643\" data-ts=\"1553804010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446643-biocept-beats-0_16-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept beats by $0.16, misses on revenue</a></h4><ul><li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>): Q4 GAAP EPS of -$1.43 <span style=\"color:green\">beats by $0.16</span>.</li><li>Revenue of $0.86M (-14.0% Y/Y) <font color=\"red\">misses by $0.02M</font>.</li><li>Shares <font color=\"green\">+3.39%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17459081-biocept-reports-2018-fourth-quarter-full-year-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446643\" data-linked=\"Biocept beats by $0.16, misses on revenue\" data-tweet=\"$BIOC - Biocept beats by $0.16, misses on revenue https://seekingalpha.com/news/3446643-biocept-beats-0_16-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3446643-biocept-beats-0_16-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446639\" data-ts=\"1553803995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446639-celgene-down-late-ahead-of-iss-decision-on-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene down late ahead of ISS decision on merger</a></h4><ul><li>Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color=\"red\">-1.4%</font>) experienced some late-session softness ahead of an expected decision from proxy advisory firm ISS on whether it supports its planned merger with Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.3%</font>). ISS should announce its opinion in the few business days.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446639\" data-linked=\"Celgene down late ahead of ISS decision on merger\" data-tweet=\"$CELG $BMY - Celgene down late ahead of ISS decision on merger https://seekingalpha.com/news/3446639-celgene-down-late-ahead-of-iss-decision-on-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3446639-celgene-down-late-ahead-of-iss-decision-on-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446641\" data-ts=\"1553803917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HYRE\" target=\"_blank\">HYRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446641-hyrecar-misses-0_21-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HyreCar misses by $0.21, misses on revenue</a></h4><ul><li>HyreCar (NASDAQ:<a href='https://seekingalpha.com/symbol/HYRE' title='HyreCar Inc.'>HYRE</a>): Q4 GAAP EPS of -$0.31 <span style=\"color:red\">misses by $0.21</span>.</li><li>Revenue of $3.1M (+138.5% Y/Y) <font color=\"red\">misses by $0.23M</font>.</li><li>Shares <font color=\"green\">+2.3%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17459078-hyrecar-reports-record-fourth-quarter-full-year-2018-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446641\" data-linked=\"HyreCar misses by $0.21, misses on revenue\" data-tweet=\"$HYRE - HyreCar misses by $0.21, misses on revenue https://seekingalpha.com/news/3446641-hyrecar-misses-0_21-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3446641-hyrecar-misses-0_21-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446636\" data-ts=\"1553803728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHMA\" target=\"_blank\">CHMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446636-chiasma-readies-equity-offering-shares-down-13-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chiasma readies equity offering; shares down 13% after hours</a></h4><ul><li>Chiasma (NASDAQ:<a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a>) is down <font color=\"red\">13%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17459042-chiasma-announces-proposed-offering-common-stock\" target=\"_blank\">planned stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446636\" data-linked=\"Chiasma readies equity offering; shares down 13% after hours\" data-tweet=\"$CHMA - Chiasma readies equity offering; shares down 13% after hours https://seekingalpha.com/news/3446636-chiasma-readies-equity-offering-shares-down-13-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3446636-chiasma-readies-equity-offering-shares-down-13-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446628\" data-ts=\"1553803487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446628-california-governor-slams-pg-and-e-board-revamp-effort\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">California governor slams PG&amp;E board revamp effort</a></h4><ul><li><a href=\"https://www.sfchronicle.com/business/article/California-deserves-better-Gov-Newsom-13724255.php\" target=\"_blank\">California's Gov. Newsom blasts</a> PG&amp;E's (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-2.5%</font>) plan to overhaul its board of directors,  accusing the company of \"prioritizing quick profits for Wall Street over public safety and reliable and affordable energy service\" for Californians.</li><li>Newsom urges PG&amp;E to reconsider picks for its board, saying he was \"troubled\" to learn the company plans  to add \"hedge fund financiers, out-of-state executives and others with  little or no experience in California and utility operations.\"</li><li>Newsom says PG&amp;E's board should be comprised by a majority of  Californians with experience as regulators, safety experts and \"clean  energy leaders.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3446628\" data-linked=\"California governor slams PG&amp;E board revamp effort\" data-tweet=\"$PCG - California governor slams PG&amp;E board revamp effort https://seekingalpha.com/news/3446628-california-governor-slams-pg-and-e-board-revamp-effort?source=tweet\" data-url=\"https://seekingalpha.com/news/3446628-california-governor-slams-pg-and-e-board-revamp-effort\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446617\" data-ts=\"1553800755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446617-gold-futures-tumble-below-1300-dollar-rises\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold futures tumble below $1,300 as dollar rises</a></h4><ul><li>Gold stocks trade broadly lower as Comex futures suffer their largest single-day percentage decline since August and <a href=\"https://www.marketwatch.com/story/gold-on-track-for-3-session-skid-as-dollar-gains-traction-higher-2019-03-28\" target=\"_blank\">settle below $1,300/oz.</a> for the first time in two weeks; front-month gold <font color=\"red\">-1.6%</font> to $1,295.30.</li><li>A stronger dollar has hurt gold and U.S. Treasury yields have halted their recent slide, a negative for gold because it becomes less attractive to yield-seeking investors when yields rise.</li><li>Elsewhere in precious metals, most-active palladium futures sank 7.9% to $1,309.70/oz. for a 16% slump from last week\u2019s all-time highs, while platinum and silver also fell ~2%.</li><li>Among major gold names: <a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color=\"red\">-3.1%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color=\"red\">-3.6%</font>, <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color=\"red\">-2.8%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color=\"red\">-2.4%</font>, <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a> <font color=\"red\">-9.3%</font>, <a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color=\"red\">-6.3%</font>, <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color=\"red\">-5.7%</font>, <a href='https://seekingalpha.com/symbol/KL' title='Kirkland Lake Gold Ltd.'>KL</a> <font color=\"red\">-5.9%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>, <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>, <a href='https://seekingalpha.com/symbol/PALL' title='ETFS Physical Palladium Shares ETF'>PALL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/SGDJ' title='Sprott Junior Gold Miners ETF'>SGDJ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/GOAU' title='U.S. Global GO GOLD and Precious Metal Miners ETF'>GOAU</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446617\" data-linked=\"Gold futures tumble below $1,300 as dollar rises\" data-tweet=\"$GOLD $KGC $AUY - Gold futures tumble below $1,300 as dollar rises https://seekingalpha.com/news/3446617-gold-futures-tumble-below-1300-dollar-rises?source=tweet\" data-url=\"https://seekingalpha.com/news/3446617-gold-futures-tumble-below-1300-dollar-rises\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446614\" data-ts=\"1553800218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446614-report-hud-also-probing-google-twitter-over-ad-discrimination\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: HUD also probing Google, Twitter over ad discrimination</a></h4><ul>   <li>Along with <a href=\"https://seekingalpha.com/news/3446457-facebook-charged-fair-housing-act-violations\" target=\"_blank\">charging Facebook</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a>) with Fair Housing Act violations today, the Dept. of Housing and Urban Development is <a href=\"https://www.washingtonpost.com/business/2019/03/28/hud-charges-facebook-with-housing-discrimination/?noredirect=on&amp;utm_term=.c91a7aaaf710\" target=\"_blank\">examining policies at Twitter</a> (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color=\"green\">+1.7%</font>) and Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color=\"red\">-0.4%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color=\"red\">-0.5%</font>) over the same issue, <i>The Washington Post</i> reports.</li>    <li>\"They want to make sure that other companies aren\u2019t getting away with something that one company is investigated for,\u201d a source tells the <i>Post.</i></li>    <li>The probe of Facebook reportedly began in late 2016, and Google and Twitter were informed late last year that they were being examined, according to the report, meaning action could be coming their way in some months.</li>     <li>Scrutiny of all tech platforms (with addressable advertising) as potentially enabling housing discrimination perked up last summer when Facebook <a href=\"https://seekingalpha.com/news/3383972-facebook-gets-hud-complaint-charging-housing-discrimination\" target=\"_blank\">faced a HUD complaint over the matter</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446614\" data-linked=\"Report: HUD also probing Google, Twitter over ad discrimination\" data-tweet=\"$FB $GOOG $GOOGL - Report: HUD also probing Google, Twitter over ad discrimination https://seekingalpha.com/news/3446614-report-hud-also-probing-google-twitter-over-ad-discrimination?source=tweet\" data-url=\"https://seekingalpha.com/news/3446614-report-hud-also-probing-google-twitter-over-ad-discrimination\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446609\" data-ts=\"1553799460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLNX\" target=\"_blank\">XLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446609-baird-raises-xilinx-pt-on-order-momentum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird raises Xilinx PT on order momentum</a></h4><ul><li>Baird raises its Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>) price target from $120 to $130 citing \"continued meaningful\" order momentum driven by the growing 5G tech demand.</li><li>Analyst Tristan Gerra also sees \"ongoing market share gains\" in industrial and auto chips plus upcoming gains in data center.</li><li>Rating maintained at Outperform.</li><li>Xilinx shares are <font color=\"green\">up 1.3%</font> to $126.81.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446609\" data-linked=\"Baird raises Xilinx PT on order momentum\" data-tweet=\"$XLNX - Baird raises Xilinx PT on order momentum https://seekingalpha.com/news/3446609-baird-raises-xilinx-pt-on-order-momentum?source=tweet\" data-url=\"https://seekingalpha.com/news/3446609-baird-raises-xilinx-pt-on-order-momentum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446606\" data-ts=\"1553799037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446606-safe-t-group-leads-technology-gainers-innodata-and-sprint-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Safe-T Group leads technology gainers; Innodata and Sprint among losers</a></h4><ul><li><b>Gainers:</b> Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"green\">+32%</font>. Eltek (NASDAQ:<a href='https://seekingalpha.com/symbol/ELTK' title='Eltek Ltd.'>ELTK</a>) <font color=\"green\">+30%</font>. JMU (NASDAQ:<a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a>) <font color=\"green\">+26%</font>. Creative Realities (NASDAQ:<a href='https://seekingalpha.com/symbol/CREX' title='Creative Realities, Inc.'>CREX</a>) <font color=\"green\">+18%</font>. Quantenna Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNA' title='Quantenna Communications, Inc.'>QTNA</a>) <font color=\"green\">+18%</font>.</li><li><b>Losers:</b> Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings plc'>NLSN</a>) <font color=\"red\">-10%</font>. Helios and Matheson Analytics (<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics Inc.'>OTC:HMNY</a>) <font color=\"red\">-10%</font>. Innodata (NASDAQ:<a href='https://seekingalpha.com/symbol/INOD' title='Innodata Inc.'>INOD</a>) <font color=\"red\">-9%</font>. Summit Wireless Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/WISA' title='Summit Wireless Technologies, Inc.'>WISA</a>) <font color=\"red\">-8%</font>. Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446606\" data-linked=\"Safe-T Group leads technology gainers; Innodata and Sprint among losers\" data-tweet=\"$SFET $ELTK $JMU - Safe-T Group leads technology gainers; Innodata and Sprint among losers https://seekingalpha.com/news/3446606-safe-t-group-leads-technology-gainers-innodata-and-sprint-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446606-safe-t-group-leads-technology-gainers-innodata-and-sprint-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446605\" data-ts=\"1553798641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPHI\" target=\"_blank\">IPHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446605-stifel-raises-inphi-on-growth-drivers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel raises Inphi on growth drivers</a></h4><ul><li>Stifel raises its Inphi (NYSE:<a href='https://seekingalpha.com/symbol/IPHI' title='Inphi Corporation'>IPHI</a>) price target from $48 to a Street-high $50 citing growth drivers that provide a \"strong road map\" to impressive revenue growth \"well into CY21 and beyond.\"</li><li>Rating maintained at Buy.</li><li>Inphi shares are <font color=\"green\">up 1%</font> to $43.80.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446605\" data-linked=\"Stifel raises Inphi on growth drivers\" data-tweet=\"$IPHI - Stifel raises Inphi on growth drivers https://seekingalpha.com/news/3446605-stifel-raises-inphi-on-growth-drivers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446605-stifel-raises-inphi-on-growth-drivers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446596\" data-ts=\"1553797584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TREX\" target=\"_blank\">TREX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446596-trexplus-5-after-stifel-upgrades-to-buy-dismisses-weather-worries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trex +5% after Stifel upgrades to Buy, dismisses weather worries</a></h4><ul><li>Trex (<a href='https://seekingalpha.com/symbol/TREX' title='Trex Company, Inc.'>TREX</a> <font color='green'>+5.4%</font>) surges after Stifel <a href=\"https://thefly.com/thestreet/realmoney/index.php/TREXid2885343/TREX-Trex-Company-upgraded-to-Buy-from-Hold-at-Stifel\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $72 price target, raised from $70, saying the stock is trading at an attractive level with a risk/reward \"very favorable\" below $60.</li><li>Stifel's John Baugh attributes Trex's recent selloff to weather fears, elevated inventory at year end, and weakness in the commercial business.</li><li>But Baugh believes \"weather to date does not really matter\" for Trex and that shelf space gains in the big boxes and two-steppers are being overlooked.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446596\" data-linked=\"Trex +5% after Stifel upgrades to Buy, dismisses weather worries\" data-tweet=\"$TREX - Trex +5% after Stifel upgrades to Buy, dismisses weather worries https://seekingalpha.com/news/3446596-trexplus-5-after-stifel-upgrades-to-buy-dismisses-weather-worries?source=tweet\" data-url=\"https://seekingalpha.com/news/3446596-trexplus-5-after-stifel-upgrades-to-buy-dismisses-weather-worries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446593\" data-ts=\"1553796930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHD\" target=\"_blank\">CHD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446593-church-dwight-rallies-after-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Church &amp; Dwight rallies after acquisition</a></h4><ul> <li>Church &amp; Dwight (<a href='https://seekingalpha.com/symbol/CHD' title='Church & Dwight Co., Inc.'>CHD</a> <font color='green'>+3.6%</font>) rallies to a new high after the company's deal to acquire the Flawless and Finishing Touch brands is looked at favorably by investors and analysts.</li> <li>Bloomberg Intelligence analyst Diana Gomes says the company's planned purchase uses a chunk of its allotted M&amp;A cash, while retaining a solid credit rating. BI thinks the deal should lead to buoyant sales abroad and online.</li> <li>Jefferies and Consumer Edge Research are also out with notes calling the acquisition attractive.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446497-church-and-dwight-add-women-s-electric-hair-removal-products-900m-including-earn\" target=\"_blank\">Church &amp; Dwight to add women\u2019s electric hair removal products for $900M including earn-out</a> (March 28)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446593\" data-linked=\"Church &amp; Dwight rallies after acquisition\" data-tweet=\"$CHD - Church &amp; Dwight rallies after acquisition https://seekingalpha.com/news/3446593-church-dwight-rallies-after-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3446593-church-dwight-rallies-after-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446590\" data-ts=\"1553796399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASRT\" target=\"_blank\">ASRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446590-assertio-up-7-on-favorable-nucynta-patent-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Assertio up 7% on favorable Nucynta patent ruling</a></h4><ul><li>Assertio Therapeutics (<a href='https://seekingalpha.com/symbol/ASRT' title='Assertio Therapeutics, Inc.'>ASRT</a> <font color=\"green\">+6.6%</font>) is up on 40% higher volume on the heels of a <a href=\"https://seekingalpha.com/pr/17458926-assertio-therapeutics-announces-favorable-nucynta-patent-ruling\" target=\"_blank\">favorable ruling</a> from a U.S. appeals court validating its U.S. Patent No. 7,994,364 covering pain med NUCYNTA (tapentadol), protecting its exclusivity until December 2025.</li><li>The company sued three generic drug makers for infringement after they filed marketing applications. The appeals court found that two of the three filings do not infringe on another valid patent, No. 8,536,130, that covers NUCYNTA until March 2029.</li><li>It receives sales-based royalties from Collegium Pharmaceutical (<a href='https://seekingalpha.com/symbol/COLL' title='Collegium Pharmaceutical, Inc.'>COLL</a> <font color=\"green\">+1.5%</font>). Per Collegium guidance, Assertio expects $120M in royalties this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446590\" data-linked=\"Assertio up 7% on favorable Nucynta patent ruling\" data-tweet=\"$ASRT $COLL - Assertio up 7% on favorable Nucynta patent ruling https://seekingalpha.com/news/3446590-assertio-up-7-on-favorable-nucynta-patent-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3446590-assertio-up-7-on-favorable-nucynta-patent-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446586\" data-ts=\"1553796081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446586-ranger-energy-services-and-zk-international-among-energy-materials-gainers-sibanye-gold-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ranger Energy Services and ZK International among Energy/Materials gainers; Sibanye Gold and Golden Star Resources among losers</a></h4><ul><li><b>Gainers: </b>Ranger Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/RNGR' title='Ranger Energy Services, Inc.'>RNGR</a>) <font color=\"green\">+13%</font>. ZK International (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"green\">+11%</font>. Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"green\">+10%</font>. Emerge Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a>) <font color=\"green\">+8%</font>. Superior Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"red\">-9%</font>. Golden Star Resources (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSS' title='Golden Star Resources Ltd.'>GSS</a>) <font color=\"red\">-7%</font>. Seabridge Gold (NYSE:<a href='https://seekingalpha.com/symbol/SA' title='Seabridge Gold Inc.'>SA</a>) <font color=\"red\">-6%</font>. AngloGold Ashanti (NYSE:<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a>) <font color=\"red\">-6%</font>. Kirkland Lake Gold (NYSE:<a href='https://seekingalpha.com/symbol/KL' title='Kirkland Lake Gold Ltd.'>KL</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446586\" data-linked=\"Ranger Energy Services and ZK International among Energy/Materials gainers; Sibanye Gold and Golden Star Resources among losers\" data-tweet=\"$RNGR $ZKIN $LEU - Ranger Energy Services and ZK International among Energy/Materials gainers; Sibanye Gold and Golden Star Resources among losers https://seekingalpha.com/news/3446586-ranger-energy-services-and-zk-international-among-energy-materials-gainers-sibanye-gold-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3446586-ranger-energy-services-and-zk-international-among-energy-materials-gainers-sibanye-gold-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446580\" data-ts=\"1553795061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446580-nielsen-jd-com-team-on-pricing-promotion-product\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen, JD.com team on pricing/promotion product</a></h4><ul>   <li>Ratings giant Nielsen (<a href=\"http://seekingalpha.com/symbol/NLSN\" target=\"_blank\">NLSN</a> <font color=\"red\">-10.3%</font>) and e-commerce's JD.com (<a href=\"http://seekingalpha.com/symbol/JD\" target=\"_blank\">JD</a> <font color=\"green\">+0.3%</font>) will sign a strategic cooperation and data-sharing agreement resulting in a <a href=\"https://seekingalpha.com/pr/17458626-nielsen-jd-jointly-launched-product-pricing-promotion-better-understands-online-consumers\" target=\"_blank\">joint product for pricing and promotion</a>.</li>    <li>The two have launched Online Pricing Optimizer, a tool to help brands evaluate pricing and optimize promotion on JD's platform.</li>    <li>It's designed based on Nielsen's traditional pricing and analysis product, but with the individual order data provided by more than 300M active JD consumers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446498-nielsen-minus-9_5-percent-amid-weaker-case-sale\" target=\"_blank\">Nielsen -9.5% amid weaker case for sale</a> (Mar. 28 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446580\" data-linked=\"Nielsen, JD.com team on pricing/promotion product\" data-tweet=\"$NLSN $JD - Nielsen, JD.com team on pricing/promotion product https://seekingalpha.com/news/3446580-nielsen-jd-com-team-on-pricing-promotion-product?source=tweet\" data-url=\"https://seekingalpha.com/news/3446580-nielsen-jd-com-team-on-pricing-promotion-product\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446570\" data-ts=\"1553792783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRA\" target=\"_blank\">NTRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446570-natera-up-11-on-draft-reimbursement-for-prospera-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natera up 11% on draft reimbursement for Prospera test</a></h4><ul><li>Natera (<a href='https://seekingalpha.com/symbol/NTRA' title='Natera, Inc.'>NTRA</a> <font color=\"green\">+11.4%</font>) is up on below-average volume in apparent response to <a href=\"https://seekingalpha.com/pr/17458852-medicare-issues-draft-local-coverage-determination-nateras-new-prospera-kidney-transplant\" target=\"_blank\">draft coverage</a> from Medicare administrative contractor Palmetto GBA under its MolDx (molecular diagnostic test) program for the Prospera donor-derived cell-free DNA test to detect active rejection in kidney transplant recipients.</li><li>The draft, called a local coverage determination or LCD, is subject to public comments and further Medicare review before being finalized.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446570\" data-linked=\"Natera up 11% on draft reimbursement for Prospera test\" data-tweet=\"$NTRA - Natera up 11% on draft reimbursement for Prospera test https://seekingalpha.com/news/3446570-natera-up-11-on-draft-reimbursement-for-prospera-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3446570-natera-up-11-on-draft-reimbursement-for-prospera-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446568\" data-ts=\"1553792533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446568-china-internet-nationwide-financial-services-leads-financial-gainers-carver-bancorp-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Internet Nationwide Financial Services leads financial gainers; Carver Bancorp and Broadway Financial among losers</a></h4><ul><li><b>Gainers:</b> China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"green\">+41%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"green\">+12%</font>. LM Funding America (NASDAQ:<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a>) <font color=\"green\">+9%</font>. People's Utah Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/PUB' title='People&#39;s Utah Bancorp'>PUB</a>) <font color=\"green\">+6%</font>. Summit State Bank (NASDAQ:<a href='https://seekingalpha.com/symbol/SSBI' title='Summit State Bank'>SSBI</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> OptimumBank Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OPHC' title='OptimumBank Holdings, Inc.'>OPHC</a>) <font color=\"red\">-14%</font>. Carver Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a>) <font color=\"red\">-12%</font>. Cohen &amp; Company (NYSEMKT:<a href='https://seekingalpha.com/symbol/COHN' title='Cohen & Company Inc.'>COHN</a>) <font color=\"red\">-10%</font>. Broadway Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/BYFC' title='Broadway Financial Corporation'>BYFC</a>) <font color=\"red\">-7%</font>. Wheeler Real Estate Investment Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust, Inc.'>WHLR</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446568\" data-linked=\"China Internet Nationwide Financial Services leads financial gainers; Carver Bancorp and Broadway Financial among losers\" data-tweet=\"$CIFS $CBL $LMFA - China Internet Nationwide Financial Services leads financial gainers; Carver Bancorp and Broadway Financial among losers https://seekingalpha.com/news/3446568-china-internet-nationwide-financial-services-leads-financial-gainers-carver-bancorp-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3446568-china-internet-nationwide-financial-services-leads-financial-gainers-carver-bancorp-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446566\" data-ts=\"1553792514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446566-aqua-metals-and-highway-holdings-among-industrial-gainers-ocean-power-technologies-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aqua Metals and Highway Holdings among industrial gainers; Ocean Power Technologies among losers</a></h4><ul><li><b>Gainers: </b>Euro Tech Holdings Company (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"green\">+146%</font>. Highway Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HIHO' title='Highway Holdings Limited'>HIHO</a>) <font color=\"green\">+9%</font>. Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"green\">+10%</font>. China Advanced Construction Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a>) <font color=\"green\">+7%</font>. Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Coda Octopus Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CODA' title='Coda Octopus Group, Inc.'>CODA</a>) <font color=\"red\">-11%</font>. LiqTech International (NYSEMKT:<a href='https://seekingalpha.com/symbol/LIQT' title='LiqTech International, Inc.'>LIQT</a>) <font color=\"red\">-5%</font>. Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446566\" data-linked=\"Aqua Metals and Highway Holdings among industrial gainers; Ocean Power Technologies among losers\" data-tweet=\"$CLWT $HIHO $ATIS - Aqua Metals and Highway Holdings among industrial gainers; Ocean Power Technologies among losers https://seekingalpha.com/news/3446566-aqua-metals-and-highway-holdings-among-industrial-gainers-ocean-power-technologies-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3446566-aqua-metals-and-highway-holdings-among-industrial-gainers-ocean-power-technologies-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446563\" data-ts=\"1553791706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446563-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>Euro Tech Holdings Company (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"green\">+129%</font>. Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a>) <font color=\"green\">+40%</font>. Tricida (NASDAQ:<a href='https://seekingalpha.com/symbol/TCDA' title='Tricida, Inc.'>TCDA</a>) <font color=\"green\">+38%</font>. China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"green\">+38%</font>. JMU Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a>) <font color=\"green\">+29%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"green\">+20%. </font>Movado Group (NYSE:<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a>) <font color=\"green\">+18%</font>. MYOS RENS Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology Inc.'>MYOS</a>) <font color=\"green\">+17%</font>. Integrated Media Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/IMTE' title='Integrated Media Technology Limited'>IMTE</a>) <font color=\"green\">+17%. </font>Quantenna Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNA' title='Quantenna Communications, Inc.'>QTNA</a>) <font color=\"green\">+17%</font>.</li><li><strong>Losers: </strong>Proteon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTO' title='Proteon Therapeutics, Inc.'>PRTO</a>) <font color=\"red\">-85%</font>. Reebonz Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"red\">-44%</font>. American Renal Associates Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings, Inc.'>ARA</a>) <font color=\"red\">-39%</font>. Osmotica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/OSMT' title='Osmotica Pharmaceuticals plc'>OSMT</a>) <font color=\"red\">-37%</font>. IMAC Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/IMAC' title='IMAC Holdings, Inc.'>IMAC</a>) <font color=\"red\">-29%</font>. Castor Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRM' title='Castor Maritime Inc.'>CTRM</a>) <font color=\"red\">-26%</font>. Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences Ltd.'>TRPX</a>) <font color=\"red\">-22%</font>. Novan (NASDAQ:<a href='https://seekingalpha.com/symbol/NOVN' title='Novan, Inc.'>NOVN</a>) <font color=\"red\">-22%</font>. YogaWorks (NASDAQ:<a href='https://seekingalpha.com/symbol/YOGA' title='YogaWorks, Inc.'>YOGA</a>) <font color=\"red\">-18%</font>. EyePoint Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) <font color=\"red\">-17%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446563\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CLWT $PLAG $TCDA - Midday Gainers / Losers https://seekingalpha.com/news/3446563-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446563-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446559\" data-ts=\"1553790972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446559-brazil-dam-disaster-knock-2019-vale-sales-volumes-75m-mt-cfo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil dam disaster could knock 2019 Vale sales volumes by 75M mt, CFO says</a></h4><ul><li>Vale's (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-2.6%</font>) iron ore sales could be <a href=\"https://www.reuters.com/article/us-vale-sa-results-outlook/brazil-mining-disaster-could-cost-vale-75-million-tonnes-in-2019-sales-cfo-idUSKCN1R91UC\" target=\"_blank\">cut by as much as 75M mt/year</a> this year as a result of January's deadly dam collapse, with a 50M mt/year reduction in sales under the most optimistic scenario, CFO Luciano Siani says.</li><li>In today's earnings conference call, Siani expressed confidence that a deal will be reached with authorities in the coming weeks on restarting Brucutu, one of its largest mines in the state of Minas Gerais, where dam disasters occurred this year and in 2015.</li><li>Vale said its worst-case guidance for FY 2019 would leave sales volumes at 307M metric tons, a big drop from its earlier 382M mt full-year forecast but nearly flat vs. sales of 309M mt achieved in 2018.</li><li>The company reported a <a href=\"https://seekingalpha.com/news/3446399-vale-profits-jumped-quarter-dam-burst-little-new-info-disaster-cost\" target=\"_blank\">big jump in Q4 profit</a>, the last full quarter before January's deadly dam burst.</li><li>In a reminder of the continued tense atmosphere in the state, Vale last night <a href=\"https://www.reuters.com/article/us-vale-sa-disaster/brazils-vale-activates-alarms-near-tailings-dams-amid-risk-of-rupture-idUSKCN1R91G2?il=0\" target=\"_blank\">activated alarms</a> in areas below three tailings dams due to an elevated risk of rupture.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446559\" data-linked=\"Brazil dam disaster could knock 2019 Vale sales volumes by 75M mt, CFO says\" data-tweet=\"$VALE - Brazil dam disaster could knock 2019 Vale sales volumes by 75M mt, CFO says https://seekingalpha.com/news/3446559-brazil-dam-disaster-knock-2019-vale-sales-volumes-75m-mt-cfo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3446559-brazil-dam-disaster-knock-2019-vale-sales-volumes-75m-mt-cfo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446556\" data-ts=\"1553789924\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGG\" target=\"_blank\">NGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446556-national-gridminus-4-on-report-u-k-labour-party-plans-to-re-nationalize-utility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Grid -4% on report U.K. Labour party plans to re-nationalize utility</a></h4><ul><li>National Grid (<a href='https://seekingalpha.com/symbol/NGG' title='National Grid plc'>NGG</a> <font color='red'>-4.6%</font>) tumbles after the BBC reported that the U.K.'s Labour party is preparing to announce <a href=\"https://www.reuters.com/article/us-nationalgrid-stocks/national-grid-shares-fall-on-report-uk-opposition-labour-party-plans-to-renationalize-utility-idUSKCN1R91T2\" target=\"_blank\">plans to re-nationalize the utility</a>.</li><li>BBC pulled the report after Labour leader Jeremy Corbyn delayed a speech he was due to make this morning announcing the policy.</li><li>The next U.K. election is not due until 2022 and there is no guarantee that Labour would win, but the deadlock over the chaotic Brexit process has increased the chances of a vote this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446556\" data-linked=\"National Grid -4% on report U.K. Labour party plans to re-nationalize utility\" data-tweet=\"$NGG - National Grid -4% on report U.K. Labour party plans to re-nationalize utility https://seekingalpha.com/news/3446556-national-gridminus-4-on-report-u-k-labour-party-plans-to-re-nationalize-utility?source=tweet\" data-url=\"https://seekingalpha.com/news/3446556-national-gridminus-4-on-report-u-k-labour-party-plans-to-re-nationalize-utility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446555\" data-ts=\"1553789525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYOS\" target=\"_blank\">MYOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446555-myos-rens-up-20-after-q4-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myos Rens up 20% after Q4 report</a></h4><ul><li>Thinly traded nano cap MYOS RENS Technology (<a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology Inc.'>MYOS</a> <font color=\"green\">+19.8%</font>) is up on triple normal volume, albeit on turnover of only 155K shares, following the release of <a href=\"https://seekingalpha.com/pr/17457780-myos-rens-technology-reports-fourth-quarter-fiscal-2018-results\" target=\"_blank\">Q4 and 2018 results</a>.</li><li>2018 revenues were $360K. Net loss was ($ 3.2M).</li><li>The company has expanded its marketing partnership with IMG aimed at introducing its Yolked products to colleges across the country. Its sales deal with The Vitamin Shoppe supporting the Yolked brand started \"in earnest\" earlier this quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446555\" data-linked=\"Myos Rens up 20% after Q4 report\" data-tweet=\"$MYOS - Myos Rens up 20% after Q4 report https://seekingalpha.com/news/3446555-myos-rens-up-20-after-q4-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3446555-myos-rens-up-20-after-q4-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446548\" data-ts=\"1553788912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446548-lululemon-athletica-and-pvh-among-consumer-gainers-sportsmans-warehouse-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon Athletica and PVH among consumer gainers; Sportsman&#39;s Warehouse leads the losers</a></h4><ul><li><b>Gainers: </b>Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a>) <font color=\"green\">+57%</font>. Movado Group (NYSE:<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a>) <font color=\"green\">+18%</font>. Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"green\">+16%</font>. PVH (NYSE:<a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a>) <font color=\"green\">+15%</font>. Lululemon Athletica (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) <font color=\"green\">+15%</font>.</li><li><b>Losers: </b>Sportsman's Warehouse (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>) <font color=\"red\">-14%</font>. WABCO Holdings (NYSE:<a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a>) <font color=\"red\">-10%</font>. The Alkaline Water Company (NASDAQ:<a href='https://seekingalpha.com/symbol/WTER' title='The Alkaline Water Company Inc.'>WTER</a>) <font color=\"red\">-7%</font>. Energy Focus (NASDAQ:<a href='https://seekingalpha.com/symbol/EFOI' title='Energy Focus, Inc.'>EFOI</a>) <font color=\"red\">-6%</font>. Jerash Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/JRSH' title='Jerash Holdings &#40;US&#41;, Inc.'>JRSH</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446548\" data-linked=\"Lululemon Athletica and PVH among consumer gainers; Sportsman&#39;s Warehouse leads the losers\" data-tweet=\"$PLAG $MOV $FFHL - Lululemon Athletica and PVH among consumer gainers; Sportsman&#39;s Warehouse leads the losers https://seekingalpha.com/news/3446548-lululemon-athletica-and-pvh-among-consumer-gainers-sportsmans-warehouse-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446548-lululemon-athletica-and-pvh-among-consumer-gainers-sportsmans-warehouse-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446545\" data-ts=\"1553788047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446545-anglogold-to-move-forward-tropicana-mine-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AngloGold to move forward with Tropicana mine expansion</a></h4><ul><li>AngloGold Ashanti (<a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color='red'>-5.2%</font>) and joint venture partner Independence Group have <a href=\"http://www.mining.com/anglogold-ashanti-to-go-ahead-with-underground-expansion-of-tropicana-mine/\" target=\"_blank\">approved a $79.3M underground expansion</a> at their Tropicana gold mine in Western Australia.</li><li>The companies expect the Boston Shaker project to contribute higher-grade mill feed that results in an improved gold production profile and enhanced cash flow.</li><li>Once the underground portion is operative, Tropicana will be able to maintain gold production at 450K-500K oz./year over five years through 2023.</li><li>Boston Shaker is expected to contribute ~100K oz./year,  with first gold expected during Q3 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446545\" data-linked=\"AngloGold to move forward with Tropicana mine expansion\" data-tweet=\"$AU - AngloGold to move forward with Tropicana mine expansion https://seekingalpha.com/news/3446545-anglogold-to-move-forward-tropicana-mine-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3446545-anglogold-to-move-forward-tropicana-mine-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446543\" data-ts=\"1553787891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCDA\" target=\"_blank\">TCDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446543-tricidas-lead-candidate-successful-in-ckd-extension-study-shares-up-38\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tricida&#39;s lead candidate successful in CKD extension study; shares up 38%</a></h4><ul><li>Thinly traded <a href=\"https://www.tricida.com/company/\" target=\"_blank\">Tricida </a>(<a href='https://seekingalpha.com/symbol/TCDA' title='Tricida, Inc.'>TCDA</a> <font color=\"green\">+37.6%</font>) is up more than a 6x surge in volume on the heels of <a href=\"https://seekingalpha.com/pr/17457933-tricida-announces-positive-results-long-term-clinical-trial-trc101-patients-ckd-metabolic\" target=\"_blank\">positive results</a> from an extension study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03390842?lead=tricida&amp;rank=2\" target=\"_blank\">TRCA-301E</a>, evaluating lead drug TRC101 (veverimer) for the treatment of metabolic acidosis in chronic kidney disease &#40;CKD&#41; patients. Metabolic acidosis, excess amounts of acid in the body, is believed to accelerate the progression of CKD while increasing the risk of muscle wasting and bone density loss.</li><li>The extension study met the primary endpoint of safety and all secondary endpoints, demonstrating a durable treatment benefit over the 52-week study period, affirming the successful outcome of the 12-week <a href=\"https://clinicaltrials.gov/ct2/show/NCT03317444?lead=tricida&amp;rank=3\" target=\"_blank\">TRCA-301</a> trial.</li><li>The company expects to file a U.S. marketing application in H2.</li><li><a href=\"https://www.tricida.com/trc101/\" target=\"_blank\">Veverimer </a>is a non-absorbed polymer that binds to hydrochloric acid in the GI tract and is removed through feces excretion, thereby lowering the amount of acid in the body.</li><li>The company has also secured an <a href=\"https://seekingalpha.com/pr/17457922-tricida-announces-200-million-debt-facility-hercules-capital\" target=\"_blank\">additional $100M</a> in available debt (now at $200M) via a facility with Hercules Capital.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446543\" data-linked=\"Tricida&#39;s lead candidate successful in CKD extension study; shares up 38%\" data-tweet=\"$TCDA - Tricida&#39;s lead candidate successful in CKD extension study; shares up 38% https://seekingalpha.com/news/3446543-tricidas-lead-candidate-successful-in-ckd-extension-study-shares-up-38?source=tweet\" data-url=\"https://seekingalpha.com/news/3446543-tricidas-lead-candidate-successful-in-ckd-extension-study-shares-up-38\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446542\" data-ts=\"1553787545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWMC\" target=\"_blank\">TWMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446542-on-trans-world-entertainments-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Trans World Entertainment&#39;s Q4 results</a></h4><ul><li>Trans World Entertainment (<a href='https://seekingalpha.com/symbol/TWMC' title='Trans World Entertainment Corporation'>TWMC</a> <font color=\"green\">+1%</font>) reported Q4 revenue decrease of 12.4% Y/Y to $127.4M.</li><li>fye segment results: Revenue $78.82M (-14.7% Y/Y) and comparable sales improved 2.8%; Gross margin of 35.6% <font color=\"green\">up by 217 bps</font>; and Adj. loss from operation of $1.02M compared to $2.44M a year ago. Inventory per square foot was $60 at the end of FY18.</li><li>etailz segment results: Revenue $48.61M (-8.3% Y/Y); Gross margin of 18.9% <font color=\"green\">up by 32 bps</font>; and Adj. loss from operations of $2.57M compared to $934k a year ago.</li><li>Q4 Overall gross margin <font color=\"green\">improved by 121 bps</font> to 29.3%; and loss from operations was $65.05M compared to $32.73M a year ago.</li><li>S&amp;GA expenses decreased by 6.7% Y/Y to $39.54M; and as percentage of revenue increased 190 bps to 31%.</li><li>Q4 Adj. EBITDA was a loss of $2.25M, compared to $835k a year ago.</li><li>Cash and cash equivalents was $4.4M as of February 2, 2019.</li><li>Inventory was $95.3M (-12.9% Y/Y) at the end of FY18.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446394-trans-world-reports-q4-results\" target=\"_blank\">Trans World reports Q4 results</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446542\" data-linked=\"More on Trans World Entertainment&#39;s Q4 results\" data-tweet=\"$TWMC - More on Trans World Entertainment&#39;s Q4 results https://seekingalpha.com/news/3446542-on-trans-world-entertainments-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446542-on-trans-world-entertainments-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446541\" data-ts=\"1553787297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YOGA\" target=\"_blank\">YOGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446541-yogaworks-slides-15_8-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YogaWorks slides 15.8% post Q4 results</a></h4><ul><li>YogaWorks (<a href='https://seekingalpha.com/symbol/YOGA' title='YogaWorks, Inc.'>YOGA</a> <font color=\"red\">-15.8%</font>) reports <a href=\"https://seekingalpha.com/pr/17457383-yogaworks-inc-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4</a> revenue decrease of 3.2% Y/Y to $14.04M.</li><li>The Company closed one studio during Q4, ending the quarter with 69 studios in nine regional markets.</li><li>Adj. EBITDA was $(2.1)M compared to $(1.1)M Y/Y.</li><li>Cash and equivalents were $11.4M as of December 31, 2018.</li><li>Cash used in operating activities was $6.5M (+983.3% Y/Y).</li><li><b>Q1 2019 Outlook:</b> Net revenue $15.25-15.75M; adj. EBITDA between $(1.5)-$(1)M.</li><li><b>2019 Outlook: </b>Net revenue $60-62M; adj. EBITDA between $(6)-$(5)M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446240-yogaworks-revenue-line\" target=\"_blank\">YogaWorks revenue in-line</a> (Mar. 27 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446541\" data-linked=\"YogaWorks slides 15.8% post Q4 results\" data-tweet=\"$YOGA - YogaWorks slides 15.8% post Q4 results https://seekingalpha.com/news/3446541-yogaworks-slides-15_8-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446541-yogaworks-slides-15_8-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446536\" data-ts=\"1553786444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOVN\" target=\"_blank\">NOVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446536-novan-down-22-on-2018-report-looming-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novan down 22% on 2018 report; looming capital raise</a></h4><ul><li>Thinly traded nano cap Novan (<a href='https://seekingalpha.com/symbol/NOVN' title='Novan, Inc.'>NOVN</a> <font color=\"red\">-22.4%</font>) is down on triple normal volume, albeit on turnover of only 203K shares, following the filing of its <a href=\"https://seekingalpha.com/filing/4420215#NOVN-12312018X10KX2018SC_HTM_S5D1EEFA00D4F5F1BB77DFC3B3DD3357F\" target=\"_blank\">2018 annual report</a> yesterday after the close. Highlights:</li><li>License and collaboration revenue: $6.0M (+163.4%); net loss: ($12.7M) (+65.3%); cash flow ops: ($28.6M) (+4.3%).</li><li>The company says its cash balance of $8.2M plus an upfront payment received this month from its commercial partner in Japan should be sufficient to fund operations into May.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446536\" data-linked=\"Novan down 22% on 2018 report; looming capital raise\" data-tweet=\"$NOVN - Novan down 22% on 2018 report; looming capital raise https://seekingalpha.com/news/3446536-novan-down-22-on-2018-report-looming-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3446536-novan-down-22-on-2018-report-looming-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446533\" data-ts=\"1553785955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446533-rbc-positive-on-western-digitals-operational-excellence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC positive on Western Digital&#39;s &#39;operational excellence&#39;</a></h4><ul><li>RBC resumes Western Digital (NASDAQ:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) at Outperform and a $55 PT citing \"operational excellence\" in the core HDD business.</li><li>The firm also attributes its positive bias to \"better than expected hyperscale spending,\" growth in Chinese handsets, and the implied long-term EPS of $11+ based on WDC's targets.</li><li>WDC shares are <font color=\"green\">up 1.7%</font> to $45.64.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446533\" data-linked=\"RBC positive on Western Digital&#39;s &#39;operational excellence&#39;\" data-tweet=\"$WDC - RBC positive on Western Digital&#39;s &#39;operational excellence&#39; https://seekingalpha.com/news/3446533-rbc-positive-on-western-digitals-operational-excellence?source=tweet\" data-url=\"https://seekingalpha.com/news/3446533-rbc-positive-on-western-digitals-operational-excellence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446532\" data-ts=\"1553785942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTDR\" target=\"_blank\">FTDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446532-frontdoor-reels-in-another-bull-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontdoor reels in another bull call</a></h4><ul> <li>Frontdoor (<a href='https://seekingalpha.com/symbol/FTDR' title='frontdoor, inc.'>FTDR</a> <font color='green'>+3.8%</font>) rallies after SunTrust launches coverage with a Buy rating on its view the company is on the verge of becoming an \"online home services behemoth.\"</li> <li>The firm assigns a price target of $40 to FTDR.</li> <li>Earlier this week, frontdoor landed <a href=\"https://seekingalpha.com/news/3445343-frontdoor-plus-1_7-percent-pair-strong-initiations\" target=\"_blank\">positive ratings</a> from Wells Fargo and JPMorgan.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446532\" data-linked=\"Frontdoor reels in another bull call\" data-tweet=\"$FTDR - Frontdoor reels in another bull call https://seekingalpha.com/news/3446532-frontdoor-reels-in-another-bull-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3446532-frontdoor-reels-in-another-bull-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446530\" data-ts=\"1553785664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446530-tenax-therapeutics-and-fibrocell-science-among-healthcare-gainers-proteon-therapeutics-lead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenax Therapeutics and Fibrocell Science among healthcare gainers; Proteon Therapeutics lead the losers</a></h4><ul><li><b>Gainers: </b>Tricida (NASDAQ:<a href='https://seekingalpha.com/symbol/TCDA' title='Tricida, Inc.'>TCDA</a>) <font color=\"green\">+36%</font>. Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) <font color=\"green\">+21%</font>. MYOS RENS Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology Inc.'>MYOS</a>) <font color=\"green\">+16%</font>. Fibrocell Science (NASDAQ:<a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a>) <font color=\"green\">+15%</font>. Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Proteon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTO' title='Proteon Therapeutics, Inc.'>PRTO</a>) <font color=\"red\">-85%</font>. Osmotica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/OSMT' title='Osmotica Pharmaceuticals plc'>OSMT</a>) <font color=\"red\">-38%</font>. American Renal Associates (NYSE:<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings, Inc.'>ARA</a>) <font color=\"red\">-37%</font>. Novan (NASDAQ:<a href='https://seekingalpha.com/symbol/NOVN' title='Novan, Inc.'>NOVN</a>) <font color=\"red\">-22%</font>. Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences Ltd.'>TRPX</a>) <font color=\"red\">-21%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446530\" data-linked=\"Tenax Therapeutics and Fibrocell Science among healthcare gainers; Proteon Therapeutics lead the losers\" data-tweet=\"$TCDA $TENX $MYOS - Tenax Therapeutics and Fibrocell Science among healthcare gainers; Proteon Therapeutics lead the losers https://seekingalpha.com/news/3446530-tenax-therapeutics-and-fibrocell-science-among-healthcare-gainers-proteon-therapeutics-lead?source=tweet\" data-url=\"https://seekingalpha.com/news/3446530-tenax-therapeutics-and-fibrocell-science-among-healthcare-gainers-proteon-therapeutics-lead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446528\" data-ts=\"1553785550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTIL\" target=\"_blank\">DTIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446528-precision-biosciences-debuts-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Precision BioSciences debuts at $18</a></h4><ul><li>IPO Precision BioSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/DTIL' title='Precision BioSciences, Inc.'>DTIL</a>) opened today at $18, 12.5% above the <a href=\"https://seekingalpha.com/news/3446346-precision-bio-prices-ipo-16\" target=\"_blank\">offering price</a> of $16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446528\" data-linked=\"Precision BioSciences debuts at $18\" data-tweet=\"$DTIL - Precision BioSciences debuts at $18 https://seekingalpha.com/news/3446528-precision-biosciences-debuts-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3446528-precision-biosciences-debuts-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446526\" data-ts=\"1553785439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446526-monster-beverage-top-pick-credit-suisse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Beverage a top pick at Credit Suisse</a></h4><ul> <li>Credit Suisse labels Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corporation'>MNST</a> <font color='red'>-0.3%</font>) a top pick on its view the growth story is still alive.</li> <li>The firm points to slowing momentum for new competitor Bang and thinks Monster can recapture market share lost to Red Bull through promotions.</li> <li>CS sets a new price target of $75, which reps +38% upside potential for shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446526\" data-linked=\"Monster Beverage a top pick at Credit Suisse\" data-tweet=\"$MNST - Monster Beverage a top pick at Credit Suisse https://seekingalpha.com/news/3446526-monster-beverage-top-pick-credit-suisse?source=tweet\" data-url=\"https://seekingalpha.com/news/3446526-monster-beverage-top-pick-credit-suisse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446525\" data-ts=\"1553785317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446525-to-skepticism-sprint-argues-too-weak-without-t-mobile\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">To skepticism, Sprint argues it&#39;s too weak without T-Mobile</a></h4><ul>   <li>Sprint's (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-2.3%</font>) case to regulators for a $26B merger with T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-2.9%</font>) leans on the assertion that it <a href=\"https://www.bloomberg.com/news/articles/2019-03-28/sprint-claim-it-s-weak-without-t-mobile-draws-u-s-skepticism\" target=\"_blank\">won't be an effective competitor without the deal</a> -- but some officials are skeptical of that, Bloomberg reports.</li>    <li>The No. 4 U.S. wireless carrier has said it might run out of cash if the merger fails, according to the report.</li>    <li>Those arguments, part of a so-called failing firm approach that suggests competition will be lessened with the failure of a player, are \"relatively weak,\" according to a former FCC wireless bureau chief.</li>    <li>Sprint and T-Mobile are also arguing that the combined company will help the U.S. win the race to 5G commercialization, though the Justice Dept. doesn't consider industrial policy, focusing instead on harm to competition.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446525\" data-linked=\"To skepticism, Sprint argues it&#39;s too weak without T-Mobile\" data-tweet=\"$S $TMUS - To skepticism, Sprint argues it&#39;s too weak without T-Mobile https://seekingalpha.com/news/3446525-to-skepticism-sprint-argues-too-weak-without-t-mobile?source=tweet\" data-url=\"https://seekingalpha.com/news/3446525-to-skepticism-sprint-argues-too-weak-without-t-mobile\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446523\" data-ts=\"1553785241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSMT\" target=\"_blank\">OSMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446523-osmotica-down-37-after-q4-report-mixed-results-for-arbaclofen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Osmotica down 37% after Q4 report, mixed results for arbaclofen</a></h4><ul><li>Ultra-thinly traded micro cap Osmotica Pharmaceuticals (<a href='https://seekingalpha.com/symbol/OSMT' title='Osmotica Pharmaceuticals plc'>OSMT</a> <font color=\"red\">-36.9%</font>) slumps on a 10x surge in volume, albeit on turnover of only 265K shares, after releasing its Q4 report after the close yesterday that contained some bad news.</li><li>Q4 revenues were $65.7M, $3.2M shy of consensus $68.9M. Full-year revenues of $263.7M missed consensus by $4.5M.</li><li>On a preliminary basis, a second Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03290131?lead=osmotica&amp;rank=2\" target=\"_blank\">OS440-3004</a>, evaluating arbaclofen extended-release tablets for the treatment of spasticity in multiple sclerosis &#40;MS&#41; patients failed to beat placebo as measured by a scale called CGIC but did demonstrate a statistically significant treatment effect as measured by another scale called TNmAS. Despite the mixed results, the company remains committed to filing a U.S. marketing application, although the timeline may extend into 2020.</li><li>Topline data from a Phase 3 study of RVL-1201 in <a href=\"https://eyewiki.aao.org/Blepharoptosis\" target=\"_blank\">blepharoptosis </a>(an abnormally low upper eyelid) should be available mid-year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446523\" data-linked=\"Osmotica down 37% after Q4 report, mixed results for arbaclofen\" data-tweet=\"$OSMT - Osmotica down 37% after Q4 report, mixed results for arbaclofen https://seekingalpha.com/news/3446523-osmotica-down-37-after-q4-report-mixed-results-for-arbaclofen?source=tweet\" data-url=\"https://seekingalpha.com/news/3446523-osmotica-down-37-after-q4-report-mixed-results-for-arbaclofen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446522\" data-ts=\"1553785125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVMK\" target=\"_blank\">SVMK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446522-suntrust-raises-svmk-target-after-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust raises SVMK target after meeting</a></h4><ul><li>SunTrust reiterates a Buy rating on SVMK (NASDAQ:<a href='https://seekingalpha.com/symbol/SVMK' title='SVMK Inc.'>SVMK</a>) and raises the PT from $17 to $19 citing a recent meeting with management.</li><li>The firm says management's \"tone reflected continued optimism around its growth initiatives\" including the enterprise business and international expansion.</li><li>SunTrust raises its 2020 and 2021 estimates to account for the recent Usabilla acquisition.</li><li>SVMK shares are <font color=\"green\">up 4.4%</font> to $17.76.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446522\" data-linked=\"SunTrust raises SVMK target after meeting\" data-tweet=\"$SVMK - SunTrust raises SVMK target after meeting https://seekingalpha.com/news/3446522-suntrust-raises-svmk-target-after-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3446522-suntrust-raises-svmk-target-after-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446521\" data-ts=\"1553784996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMT\" target=\"_blank\">CRMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446521-americas-car-mart-rides-higher-after-buckingham-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">America&#39;s Car-Mart rides higher after Buckingham nod</a></h4><ul> <li>America's Car-Mart (<a href='https://seekingalpha.com/symbol/CRMT' title='America&#39;s Car-Mart, Inc.'>CRMT</a> <font color='green'>+4.9%</font>) rallies after Buckingham Research initiates coverage with a Buy rating.</li> <li>The firm's price target of $103 reps +20% upside potential for shares. The 52-week high for CRMT is $100.75.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3446521\" data-linked=\"America&#39;s Car-Mart rides higher after Buckingham nod\" data-tweet=\"$CRMT - America&#39;s Car-Mart rides higher after Buckingham nod https://seekingalpha.com/news/3446521-americas-car-mart-rides-higher-after-buckingham-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3446521-americas-car-mart-rides-higher-after-buckingham-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446519\" data-ts=\"1553784669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNX\" target=\"_blank\">SNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446519-synnexplus-2_5-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SYNNEX +2.5% post Q1 results</a></h4><ul><li>Synnex (<a href='https://seekingalpha.com/symbol/SNX' title='SYNNEX Corporation'>SNX</a> <font color=\"green\">+2.5%</font>) reports <a href=\"https://seekingalpha.com/pr/17457425-synnex-corporation-reports-first-quarter-fiscal-2019-results\" target=\"_blank\">Q1</a> revenue growth of 16.9% Y/Y to $5.25B.</li><li>Q1 overall margins: Gross <font color=\"green\">increased 384 bps</font> to 12.95%; Operating <font color=\"green\">increased 61 bps</font> to 3.09%; adj. operating <font color=\"green\">increased 150 bps</font> to 4.62% &amp; adj. EBITDA  <font color=\"green\">increased 177 bps</font> to 5.33%.</li><li>Return on Invested Capital was 8.7% and adj. ROIC was 10.9%.</li><li>\"Most significant was the performance of our Concentrix business. In Q1, since our Convergys acquisition, the team delivered solid financial results while managing integration and providing outstanding customer service.\" said Dennis Polk, SYNNEX President and CEO.</li><li><b>Q2 2019 Outlook:</b> Revenue $5.4-5.7B; Net income of $85.3-93.9M; adj. net income of $134.9-143.5M; EPS of $1.65-1.82; adj. EPS of $2.62-2.78; diluted weighted average shares of 51.1M; after-tax amortization of intangibles of $38.2M &amp; after-tax acquisition-related and integration expense to be $11.4M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446261-synnex-declares-0_375-dividend\" target=\"_blank\">Synnex declares $0.375 dividend</a> (Mar. 27 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446260-synnex-beats-0_10-misses-revenue\" target=\"_blank\">Synnex beats by $0.10, misses on revenue</a> (Mar. 27 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446519\" data-linked=\"SYNNEX +2.5% post Q1 results\" data-tweet=\"$SNX - SYNNEX +2.5% post Q1 results https://seekingalpha.com/news/3446519-synnexplus-2_5-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446519-synnexplus-2_5-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446517\" data-ts=\"1553784122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UE\" target=\"_blank\">UE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446517-urban-edge-gains-after-outlining-strategy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Urban Edge gains after outlining strategy</a></h4><ul><li>Urban Edge Properties (<a href='https://seekingalpha.com/symbol/UE' title='Urban Edge Properties'>UE</a> <font color='green'>+2%</font>) advances after the REIT's <a href=\"https://seekingalpha.com/pr/17458041-urban-edge-properties-releases-annual-letter-shareholders\" target=\"_blank\">annual letter</a> to shareholders outlines its redevelopment opportunities, plans for its core properties, and non-core divestments. Among the letters highlights:</li><li>Sees replacement rents for properties affected by retailer bankruptcies to start in late 2019 and stabilizing in 2021--\"We now have 10 vacant anchor boxes accounting for 600,000 square feet of gross leasable area that should generate ~$15 million in annual gross rent, or $0.12/share in FFO, once leased.\"</li></ul><ol><li>Regarding 11 redevelopment projects during 2018, Urban Edge executed new and renewal leases for 1.6M square feet of space with positive rent spreads of ~4%.</li></ol><ul><li>Sees opportunity to densify four flagship properties by creating mixed-use environments; sees potential for ~$1B of investment at these properties over next 5-7 years with funding likely from its own capital, sale of development rights and/or joint venture partners.</li><li>Expects to invest $250M-$500M in 21 existing value-add properties over next several years.</li><li>For core properties, Urban Edge is evaluating seeding some of these assets into a new JV or possibly selling them over a \"measured period of time at a significant premium to valuations implied by our current stock price.\"</li><li>Will seek to divest non-core portfolio comprised of 39 smaller properties valued at ~$400M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397084-sears-looking-close-150-stores-reuters\" target=\"_blank\">Sears looking to close up to 150 stores - Reuters</a> (Oct. 12, 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446517\" data-linked=\"Urban Edge gains after outlining strategy\" data-tweet=\"$UE - Urban Edge gains after outlining strategy https://seekingalpha.com/news/3446517-urban-edge-gains-after-outlining-strategy?source=tweet\" data-url=\"https://seekingalpha.com/news/3446517-urban-edge-gains-after-outlining-strategy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446515\" data-ts=\"1553784015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARA\" target=\"_blank\">ARA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446515-american-renal-down-35-on-financial-reporting-woes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Renal down 35% on financial reporting woes</a></h4><ul><li>Thinly traded American Renal Associates (<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings, Inc.'>ARA</a> <font color=\"red\">-34.8%</font>) is down on almost a 5x surge in volume after disclosing that it will need to <a href=\"https://seekingalpha.com/news/3446286-american-renal-restate-financials-shares-7-percent-hours\" target=\"_blank\">restate</a> its past five years of financial statements due to problems in revenue recognition and other issues.</li><li>CFO Jason Boucher has <a href=\"https://seekingalpha.com/news/3446308-american-renal-associates-cfo-resigns-amid-audit-work\" target=\"_blank\">resigned </a>as a result.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446515\" data-linked=\"American Renal down 35% on financial reporting woes\" data-tweet=\"$ARA - American Renal down 35% on financial reporting woes https://seekingalpha.com/news/3446515-american-renal-down-35-on-financial-reporting-woes?source=tweet\" data-url=\"https://seekingalpha.com/news/3446515-american-renal-down-35-on-financial-reporting-woes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446514\" data-ts=\"1553783970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446514-auto-suppliers-gain-after-wabco-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto suppliers gain after WABCO buyout</a></h4><ul> <li>Auto parts stocks rally in a move being attributed to the acquisition of WABCO Holdings by ZF Friedrichshafen.</li> <li>Gainers include Westport Fuel Systems (<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a> <font color='green'>+9.2%</font>), American Axle &amp; Manufacturing (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='green'>+4%</font>), Dana (<a href='https://seekingalpha.com/symbol/DAN' title='Dana Incorporated'>DAN</a> <font color='green'>+3.4%</font>), Adient (<a href='https://seekingalpha.com/symbol/ADNT' title='Adient plc'>ADNT</a> <font color='green'>+4.1%</font>), Lear (<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a> <font color='green'>+3.1%</font>), Superior Industries (<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International, Inc.'>SUP</a> <font color='green'>+3.9%</font>), Delphi Technologies (<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a> <font color='green'>+2.1%</font>), Aptiv (<a href='https://seekingalpha.com/symbol/APTV' title='Aptiv PLC'>APTV</a> <font color='green'>+2.3%</font>), Stoneridge (<a href='https://seekingalpha.com/symbol/SRI' title='Stoneridge, Inc.'>SRI</a> <font color='green'>+3.7%</font>), Monro (<a href='https://seekingalpha.com/symbol/MNRO' title='Monro, Inc.'>MNRO</a> <font color='green'>+2.2%</font>), Motorcar Parts of America (<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a> <font color='green'>+2.2%</font>) and Tenneco (<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a> <font color='green'>+2.2%</font>).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3446431-wabco-bought-zf-friedrichshafen\" target=\"_blank\">WABCO bought out by ZF Friedrichshafen</a> (March 28)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446514\" data-linked=\"Auto suppliers gain after WABCO buyout\" data-tweet=\"$WPRT $AXL $DAN - Auto suppliers gain after WABCO buyout https://seekingalpha.com/news/3446514-auto-suppliers-gain-after-wabco-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3446514-auto-suppliers-gain-after-wabco-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446513\" data-ts=\"1553783561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446513-natural-gas-inventory-draw-missed-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory draw missed consensus</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>-36 Bcf</strong> vs. -40 Bcf consensus, -47 Bcf last week.</li><li>Futures <font color=\"red\">-0.22%</font> to $2.713.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446513\" data-linked=\"Natural gas inventory draw missed consensus\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory draw missed consensus https://seekingalpha.com/news/3446513-natural-gas-inventory-draw-missed-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3446513-natural-gas-inventory-draw-missed-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446509\" data-ts=\"1553782986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBR\" target=\"_blank\">EBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446509-eletrobrasplus-5-2018-racks-up-biggest-profit-in-20-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eletrobras +5% as 2018 racks up biggest profit in 20 years</a></h4><ul><li>Eletrobras (<a href='https://seekingalpha.com/symbol/EBR' title='Centrais Elétricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='green'>+5.8%</font>) shoots higher after reporting <a href=\"https://seekingalpha.com/news/3446485-centrais-eletricas-brasileiras-s-eletrobras-reports-q4-results\" target=\"_blank\">Q4 results</a> including a profit profit of 12.07B reais ($3.02B), a sharp turnaround from the previous year when the Brazilian utility posted a loss of 3.9B reais.</li><li>For the full year, EBR says it earned 13.3B reais, its <a href=\"https://www.reuters.com/article/eletrobras-results/brazils-eletrobras-reports-hefty-profit-boosted-by-privatizations-idUSL1N21F0CH\" target=\"_blank\">biggest profit in 20 years</a> and a reversal from 2017's 1.7B real loss.</li><li>EBR says it was helped by the reversal of impairments and contracts related to the Angra 3 nuclear power plant project, as well as the sale of several money-losing distribution subsidiaries.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446509\" data-linked=\"Eletrobras +5% as 2018 racks up biggest profit in 20 years\" data-tweet=\"$EBR $EBR.B - Eletrobras +5% as 2018 racks up biggest profit in 20 years https://seekingalpha.com/news/3446509-eletrobrasplus-5-2018-racks-up-biggest-profit-in-20-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3446509-eletrobrasplus-5-2018-racks-up-biggest-profit-in-20-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446505\" data-ts=\"1553782431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIQT\" target=\"_blank\">LIQT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446505-liqtech-international-down-5-post-q4-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LiqTech International down 5% post Q4 revenue miss</a></h4><div><ul><li>LiqTech International (<a href='https://seekingalpha.com/symbol/LIQT' title='LiqTech International, Inc.'>LIQT</a> <font color=\"red\">-5.3%</font>) reported Q4 revenue of $2.9M, a decrease of 3.3% Y/Y, due to a decline in the legacy DPF business which had revenue of $1.5M (-7% Y/Y).</li><li>Marine segment revenues $1.4M (+42% Y/Y).</li><li>Q4 Gross profit was $177k, compared to $59k a year ago.</li><li>Total operating expenses were $1.8M up by 39% Y/Y, with Selling &amp; Marketing -5% Y/Y; G&amp;A +78% Y/Y; and R&amp;D flat.</li><li>Cash on hand and restricted cash was at $3.8M as of December 31, 2018.</li><li>\"With 2018 now behind us and a continued ramping of our order backlog, we expect the first quarter of 2019 to be a significant turning point in the history of LiqTech. We are set to report record quarterly revenues of ~$7M for Q1 2019, to return the Company to profitability and we are continuing to grow our order backlog,\" commented Sune Mathiesen, CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446355-liqtech-eps-line-misses-revenue\" target=\"_blank\">LiqTech EPS in-line, misses on revenue</a> (March 28)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3446505\" data-linked=\"LiqTech International down 5% post Q4 revenue miss\" data-tweet=\"$LIQT - LiqTech International down 5% post Q4 revenue miss https://seekingalpha.com/news/3446505-liqtech-international-down-5-post-q4-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3446505-liqtech-international-down-5-post-q4-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446504\" data-ts=\"1553782168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDR\" target=\"_blank\">CLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446504-buy-cloudera-ahead-of-platform-release-rosenblatt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buy Cloudera ahead of platform release - Rosenblatt</a></h4><ul><li>Rosenblatt recommends buying Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) ahead of the common data platform release in 2H, which could prove a catalyst and show CLDR is positioned to benefit from cloud adoption.</li><li>Analyst Marshall Senk calls the recent weakness a buying opportunity.</li><li>Cloudera shares are <font color=\"green\">up 1.1%</font> to $10.79.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446504\" data-linked=\"Buy Cloudera ahead of platform release - Rosenblatt\" data-tweet=\"$CLDR - Buy Cloudera ahead of platform release - Rosenblatt https://seekingalpha.com/news/3446504-buy-cloudera-ahead-of-platform-release-rosenblatt?source=tweet\" data-url=\"https://seekingalpha.com/news/3446504-buy-cloudera-ahead-of-platform-release-rosenblatt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446500\" data-ts=\"1553781736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTGN\" target=\"_blank\">VTGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446500-vistagen-nabs-australian-patent-covering-avminus-101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VistaGen nabs Australian patent covering AV-101</a></h4><ul><li>The Australian Patent Office has issued a <a href=\"https://seekingalpha.com/pr/17458222-vistagen-therapeutics-receives-australian-patent-treatment-depression-avminus-101\" target=\"_blank\">patent </a>to VistaGen Therapeutics (<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>OTC:VTGN</a> <font color=\"green\">+1.1%</font>) covering methods of treating depression with AV-101, its Phase 2-stage candidate for major depressive disorder.</li><li>The company says the Australian patent is a counterpart to its U.S. patent issued in June 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446500\" data-linked=\"VistaGen nabs Australian patent covering AV-101\" data-tweet=\"$VTGN - VistaGen nabs Australian patent covering AV-101 https://seekingalpha.com/news/3446500-vistagen-nabs-australian-patent-covering-avminus-101?source=tweet\" data-url=\"https://seekingalpha.com/news/3446500-vistagen-nabs-australian-patent-covering-avminus-101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446498\" data-ts=\"1553781560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446498-nielsenminus-9_5-amid-weaker-case-for-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen -9.5% amid weaker case for sale</a></h4><ul>   <li>Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings plc'>NLSN</a>) is <font color=\"red\">9.5% lower</font> in the regular session in the <a href=\"https://seekingalpha.com/news/3446270-nielsen-minus-10-percent-report-blackstones-auction-company\" target=\"_blank\">aftermath of a report</a> suggesting support for a sale of the company is crumbling.</li>    <li>The <i>New York Post</i> said Blackstone would drop out of the running, and that rival bidder Apollo Global Management was also losing interest.</li>    <li>That sale is no longer a foregone conclusion, says Credit Suisse analyst Kevin McVeigh, cutting his price target to a Street-low $23 from $27 (and seeing shares down to $19 in a scenario with no deal, even for Nielsen's Watch unit).</li>    <li>That $23 target implies another 5% downside beyond the 9.5% drop today.</li>    <li>Nielsen had explored unloading its \"Watch\" segment last year before looking at selling the whole company, but a more competitive environment for Watch could crimp prices for it or Nielsen as a whole, McVeigh says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446498\" data-linked=\"Nielsen -9.5% amid weaker case for sale\" data-tweet=\"$NLSN - Nielsen -9.5% amid weaker case for sale https://seekingalpha.com/news/3446498-nielsenminus-9_5-amid-weaker-case-for-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3446498-nielsenminus-9_5-amid-weaker-case-for-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446493\" data-ts=\"1553781297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAAS\" target=\"_blank\">CAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446493-on-china-automotive-systems-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on China Automotive Systems&#39; Q4 results</a></h4><ul><li><p>China Automotive Systems (<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a> <font color='red'>-7.3%</font>) reports net sales fell 13.5% in <a href=\"https://seekingalpha.com/pr/17457790-china-automotive-systems-reports-fourth-quarter-fiscal-2018-results\" target=\"_blank\">Q4</a>, mainly due to the weaker Chinese auto market.</p><p>Gross margin rate squeezed 220 bps to 9.2%, primarily due to the decrease in net sales and change of product mix.</p><p>Selling expense rate improved 80 bps to 3.9%.</p><p>The company expects revenue of $510M for FY2019.</p><p>Previously: <a href=\"https://seekingalpha.com/news/3446347-china-automotive-systems-misses-revenue\" target=\"_blank\">China Automotive Systems misses on revenue</a> (March 28)</p></li></ul><div class=\"tiny-share-widget\" data-id=\"3446493\" data-linked=\"More on China Automotive Systems&#39; Q4 results\" data-tweet=\"$CAAS - More on China Automotive Systems&#39; Q4 results https://seekingalpha.com/news/3446493-on-china-automotive-systems-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446493-on-china-automotive-systems-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446491\" data-ts=\"1553781073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNMA\" target=\"_blank\">FNMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446491-only-start-for-frannie-reform-analysts-say\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">It&#39;s only the start for Frannie reform, analysts say</a></h4><ul><li>One thing is clear about President Trump's memo that tells the Treasury Department, HUD, and other government agencies to come up with a plan to restructure Fannie Mae (<a href='https://seekingalpha.com/symbol/FNMA' title='Federal National Mortgage Association'>OTCQB:FNMA</a> <font color='green'>+5.2%</font>) and Freddie Mac (<a href='https://seekingalpha.com/symbol/FMCC' title='Freddie Mac'>OTCQB:FMCC</a> <font color='green'>+6.2%</font>)--<a href=\"https://www.bloomberg.com/news/articles/2019-03-28/wall-street-sees-hurdles-for-trump-s-vague-fannie-freddie-plan?srnd=premium\" target=\"_blank\">nothing major</a> will happen soon, analysts say.</li><li>For one thing, the Trump administration is likely to \"proceed cautiously to avoid disrupting the mortgage and housing markets ahead of the 2020 presidential election,\" Goldman Sachs analyst Jan Hatzius writes in a note.</li><li>He sees limited impact on the housing markets, though there may be \"meaningful\" shifts for the two GSEs.</li><li>The memo does increase pressure on lawmakers to tackle the issue, \"but also clarifies that significant executive action\" isn't imminent as it may take months for agencies to craft a framework, Raymond James analyst Ed Mills says.</li><li>KBW's Bose George writes that it's unclear if GSE reform this year is feasible. \"We remain cautious on the value of the GSE shares,\" George says.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446287-white-house-issues-memo-fannie-freddie-reform\" target=\"_blank\">White House issues memo on Fannie, Freddie reform</a> (March 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446491\" data-linked=\"It&#39;s only the start for Frannie reform, analysts say\" data-tweet=\"$FNMA $FMCC - It&#39;s only the start for Frannie reform, analysts say https://seekingalpha.com/news/3446491-only-start-for-frannie-reform-analysts-say?source=tweet\" data-url=\"https://seekingalpha.com/news/3446491-only-start-for-frannie-reform-analysts-say\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446490\" data-ts=\"1553781058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEM\" target=\"_blank\">MTEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446490-molecular-templates-launches-mid-stage-study-of-mtminus-3724-in-dlbcl\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molecular Templates launches mid-stage study of MT-3724 in DLBCL</a></h4><ul><li>Molecular Templates (<a href='https://seekingalpha.com/symbol/MTEM' title='Molecular Templates, Inc.'>MTEM</a> <font color=\"green\">+0.7%</font>) <a href=\"https://seekingalpha.com/pr/17458119-molecular-templates-announces-initiation-phase-ii-monotherapy-study-mtminus-3724-relapsed\" target=\"_blank\">initiates </a>a Phase 2 clinical trial evaluating MT-3724 in up to 100 patients with relapsed/refractory diffuse large B-cell lymphoma &#40;DLBCL&#41; who have received at least two prior lines of therapy.</li><li>The primary endpoint is tumor response.</li><li>The company says <a href=\"http://mtem.com/etb-platform/mt-3724/\" target=\"_blank\">MT-3724</a> is a CD20-targeted Engineered Toxin Body &#40;ETB&#41;. It kills rogue cells by destroying the function of the ribosome and has shown efficacy in patients who failed to respond to Roche's Rituxan (rituximab).</li></ul><div class=\"tiny-share-widget\" data-id=\"3446490\" data-linked=\"Molecular Templates launches mid-stage study of MT-3724 in DLBCL\" data-tweet=\"$MTEM - Molecular Templates launches mid-stage study of MT-3724 in DLBCL https://seekingalpha.com/news/3446490-molecular-templates-launches-mid-stage-study-of-mtminus-3724-in-dlbcl?source=tweet\" data-url=\"https://seekingalpha.com/news/3446490-molecular-templates-launches-mid-stage-study-of-mtminus-3724-in-dlbcl\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446489\" data-ts=\"1553780776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UQM\" target=\"_blank\">UQM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446489-on-uqm-technologiess-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on UQM Technologies&#39;s Q4 results</a></h4><ul><li>UQM Technologies (<a href='https://seekingalpha.com/symbol/UQM' title='UQM Technologies, Inc.'>UQM</a> <font color=\"red\">-0.3%</font>) reported Q4 revenue growth of 146.4% Y/Y to $5.47M.</li><li>Q4 Net loss reduced to $959.4k, from $1.28M a year ago.</li><li>Q4 Gross margin <font color=\"red\">declined by 1,298 bps</font> to 23.7%.</li><li>Company has Cash and cash equivalents of $1.92M as of December 31, 2018.</li><li>UQM will be holding a special shareholders meeting on April 23, 2019 to vote on the Company\u2019s pending merger with Danfoss.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446278-uqm-technologies-beats-0_04-beats-revenue\" target=\"_blank\">UQM Technologies beats by $0.04, beats on revenue</a> (March 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446489\" data-linked=\"More on UQM Technologies&#39;s Q4 results\" data-tweet=\"$UQM - More on UQM Technologies&#39;s Q4 results https://seekingalpha.com/news/3446489-on-uqm-technologiess-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446489-on-uqm-technologiess-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446484\" data-ts=\"1553780211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDOC\" target=\"_blank\">TDOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446484-teladoc-expands-canada-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teladoc expands into Canada; shares up 3%</a></h4><ul><li>Teladoc (<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a> <font color=\"green\">+2.5%</font>) <a href=\"https://seekingalpha.com/pr/17458243-teladoc-health-launches-telemedicine-service-canada-expanding-portfolio-available-healthcare\" target=\"_blank\">launches </a>telemedicine services in Canada, providing patient access to a licensed physician on a 24x7x365 basis in English or French via phone or mobile app.</li><li>The company says its service, branded as Teladoc Telemedicine Services, is the first in Canada.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446484\" data-linked=\"Teladoc expands into Canada; shares up 3%\" data-tweet=\"$TDOC - Teladoc expands into Canada; shares up 3% https://seekingalpha.com/news/3446484-teladoc-expands-canada-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3446484-teladoc-expands-canada-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446480\" data-ts=\"1553779658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446480-lululemon-bid-up-to-all-time-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon bid up to all-time high</a></h4><ul> <li>Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) is on pace to open at a record high following a sizzling Q4 earnings report after new products were gobbled up by consumers. Analysts are largely issuing positive comments on the athletic apparel juggernaut.</li> <li>Oppenheimer calls LULU as one of the fastest-growing and healthiest brands in the consumer sector as it bumps it price target to $190.</li> <li>Credit Suisse thinks Lululemon management will be able to focus investors on the long-term growth story as it ups its PT to $190.</li> <li>JPMorgan has both firms beat with a PT of $197.</li> <li>There is some caution being sounded by Jefferies, with analyst Randal Konik saying LULU shares already reflect the upside from digital initiatives and international growth.</li> <li>Shares of Lululemon are <font color=\"green\">up 14.97%</font> premarket to $168.70.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446242-lululemon-athletica-beats-0_10-beats-revenue\" target=\"_blank\">Lululemon Athletica beats by $0.10, beats on revenue</a> (March 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446255-lululemon-plus-10-percent-strong-sales-report\" target=\"_blank\">Lululemon +10% after strong sales report</a> (March 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446480\" data-linked=\"Lululemon bid up to all-time high\" data-tweet=\"$LULU - Lululemon bid up to all-time high https://seekingalpha.com/news/3446480-lululemon-bid-up-to-all-time-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3446480-lululemon-bid-up-to-all-time-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446475\" data-ts=\"1553779339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446475-valeritas-inks-deal-for-v-go-in-israel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas inks deal for V-Go in Israel</a></h4><ul> <li>Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) has <a href=\"https://seekingalpha.com/pr/17457885-valeritas-announces-v-go-distribution-agreement-israel\" target=\"_blank\">signed</a> an exclusive distribution agreement with TRITECH BioMed for the commercialization of its V-Go Wearable Insulin Delivery device in Israel.</li><li>Under the terms of the agreement, TRITECH BioMed will have the rights to promote, market and sell the V-Go to diabetes clinics and patients in Israel.</li>     <li>Valeritas will retain responsibility for product development, regulatory approval, quality management, and manufacturing.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3446475\" data-linked=\"Valeritas inks deal for V-Go in Israel\" data-tweet=\"$VLRX - Valeritas inks deal for V-Go in Israel https://seekingalpha.com/news/3446475-valeritas-inks-deal-for-v-go-in-israel?source=tweet\" data-url=\"https://seekingalpha.com/news/3446475-valeritas-inks-deal-for-v-go-in-israel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446470\" data-ts=\"1553779116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446470-eyepoint-prices-stock-offering-1_90-shares-down-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyePoint prices stock offering at $1.90; shares down 14% premarket</a></h4><ul><li>Thinly traded micro cap EyePoint Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) is down <font color=\"red\">14%</font> premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/17458463-eyepoint-pharmaceuticals-announces-pricing-public-offering-common-stock\" target=\"_blank\">public offering</a> of ~10.5M common shares at $1.90 per share.</li><li>Underwriters over-allotment is an additional ~1.6M shares. Closing date is April 1.</li><li>Yesterday's close as $2.21.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446470\" data-linked=\"EyePoint prices stock offering at $1.90; shares down 14% premarket\" data-tweet=\"$EYPT - EyePoint prices stock offering at $1.90; shares down 14% premarket https://seekingalpha.com/news/3446470-eyepoint-prices-stock-offering-1_90-shares-down-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3446470-eyepoint-prices-stock-offering-1_90-shares-down-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446469\" data-ts=\"1553778986\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446469-wbc-and-eypt-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WBC and EYPT among premarket losers</a></h4><ul><li>Proteon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTO' title='Proteon Therapeutics, Inc.'>PRTO</a>) <font color=\"red\">-83%</font> after vonapanitase <a href=\"https://seekingalpha.com/news/3446435-proteons-vonapanitase-flunks-second-late-stage-study\" target=\"_blank\">flunks</a> second late-stage study.</li><li>Reebonz Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"red\">-24%</font>.</li><li>Castor Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRM' title='Castor Maritime Inc.'>CTRM</a>) <font color=\"red\">-15%</font>.</li><li>CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"red\">-12%</font> on <a href=\"https://seekingalpha.com/news/3446350-canntrust-misses-c-0_22-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>EyePoint Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) <font color=\"red\">-12%</font> on planned <a href=\"https://seekingalpha.com/news/3446266-eyepoint-pharma-8-percent-hours-planned-equity-offering\" target=\"_blank\">equity offering</a>.</li><li>Gevo (NASDAQ:<a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a>) <font color=\"red\">-12%</font> on <a href=\"https://seekingalpha.com/news/3446249-gevo-misses-0_21-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>WABCO Holdings (NYSE:<a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a>) <font color=\"red\">-10%</font> on being <a href=\"https://seekingalpha.com/news/3446431-wabco-bought-zf-friedrichshafen\" target=\"_blank\">acquired</a> by ZF Friedrichshafen for $136.50/share.</li><li>Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings plc'>NLSN</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/news/3446270-nielsen-minus-10-percent-report-blackstones-auction-company\" target=\"_blank\">report</a> Blackstone's out of auction for company.</li><li>Social Reality (NASDAQ:<a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality, Inc.'>SRAX</a>) <font color=\"red\">-8%</font>.</li><li>YogaWorks (NASDAQ:<a href='https://seekingalpha.com/symbol/YOGA' title='YogaWorks, Inc.'>YOGA</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3446240-yogaworks-revenue-line\" target=\"_blank\">Q4 earnings</a>.</li><li>Navios Maritime Containers L.P. (NASDAQ:<a href='https://seekingalpha.com/symbol/NMCI' title='Navios Maritime Containers L.P.'>NMCI</a>) <font color=\"red\">-7%</font>.</li><li>Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yirendai Ltd.'>YRD</a>) <font color=\"red\">-6%</font>.</li><li>Navios Maritime Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a>) <font color=\"red\">-6%</font>.</li><li>Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446469\" data-linked=\"WBC and EYPT among premarket losers\" data-tweet=\"$PRTO $RBZ $CTRM - WBC and EYPT among premarket losers https://seekingalpha.com/news/3446469-wbc-and-eypt-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446469-wbc-and-eypt-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446468\" data-ts=\"1553778980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446468-lulu-amrn-and-five-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LULU, AMRN and FIVE among premarket gainers</a></h4><ul><li>Euro Tech Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"green\">+145%</font>.</li><li>Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) <font color=\"green\">+25%</font>.</li><li>Quantenna Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/QTNA' title='Quantenna Communications, Inc.'>QTNA</a>) <font color=\"green\">+18%</font> as analyst <a href=\"https://seekingalpha.com/news/3446408-minimal-regulatory-risk-quantenna-deal-analysts\" target=\"_blank\">reports</a> minimal regulatory risk for ON-Quantenna deal.</li><li>Lululemon Athletica (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) <font color=\"green\">+14%</font> on <a href=\"https://seekingalpha.com/news/3446242-lululemon-athletica-beats-0_10-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>PVH (NYSE:<a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a>) <font color=\"green\">+12%</font> on <a href=\"https://seekingalpha.com/news/3446256-phillips-van-heusen-beats-0_08-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Integrated Media Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/IMTE' title='Integrated Media Technology Limited'>IMTE</a>) <font color=\"green\">+10%</font>.</li><li>Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/pr/17458276-qutoutiao-announces-investment-alibaba\" target=\"_blank\">entering</a> into a convertible loan agreement with Alibaba Investment.</li><li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"green\">+10%</font>.</li><li>Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"green\">+7%</font> on $50M streaming media <a href=\"https://seekingalpha.com/news/3446436-pareteum-plus-5_6-percent-50m-streaming-media-contract\" target=\"_blank\">contract</a>.</li><li>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) <font color=\"green\">+7%</font>.</li><li>Five Below (NASDAQ:<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below, Inc.'>FIVE</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3446239-five-inc-eps-line-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Affimed N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/AFMD' title='Affimed N.V.'>AFMD</a>) <font color=\"green\">+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446468\" data-linked=\"LULU, AMRN and FIVE among premarket gainers\" data-tweet=\"$CLWT $TENX $QTNA - LULU, AMRN and FIVE among premarket gainers https://seekingalpha.com/news/3446468-lulu-amrn-and-five-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446468-lulu-amrn-and-five-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446467\" data-ts=\"1553778777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446467-sarepta-to-file-u-s-application-for-casimersen-mid-year-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta to file U.S. application for casimersen mid-year; shares up 3% premarket</a></h4><ul><li>Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) is up <font color=\"green\">3%</font> premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17458210-sarepta-therapeutics-announces-positive-expression-results-casimersen-srpminus-4045-arm\" target=\"_blank\">announcement </a>of preliminary data from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02500381?lead=sarepta&amp;id=4045-301&amp;rank=1\" target=\"_blank\">ESSENCE</a>, evaluating casimersen and golodirsen in Duchenne muscular dystrophy &#40;DMD&#41; patients amenable to skipping exons 45 and 53, respectively.</li><li>Patients in the casimersen arm were randomized to receive once-weekly infusions of 30 mg/kg (n=27) or placebo (n=16) for 96 weeks.</li><li>Per FDA feedback, the company conducted an interim analysis to assess dystrophin protein expression in DMD patients amenable to exon 45 skipping, a surrogate efficacy endpoint. Bicep muscle biopsies at week 48 in casimersen-treated patients showed mean dystrophin protein increased to 1.736% of normal compared to a baseline of 0.925% of normal (p&lt;0.001). The mean change from baseline in dystrophin protein in the treatment group compared to placebo was statistically significant.</li><li>Although the study is ongoing, Sarepta plans to file a U.S. marketing application mid-year seeking approval for casimersen.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446467\" data-linked=\"Sarepta to file U.S. application for casimersen mid-year; shares up 3% premarket\" data-tweet=\"$SRPT - Sarepta to file U.S. application for casimersen mid-year; shares up 3% premarket https://seekingalpha.com/news/3446467-sarepta-to-file-u-s-application-for-casimersen-mid-year-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3446467-sarepta-to-file-u-s-application-for-casimersen-mid-year-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446465\" data-ts=\"1553778695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446465-papa-johns-appoints-new-cmo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s appoints new CMO</a></h4><ul> <li>Papa John's International (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) announces the appointment of       Karlin Linhardt as its new global chief marketing officer.</li><li>The company says Linhardt is a       veteran marketing leader with deep quick service restaurant category experience and C-suite executive roles at global Fortune-500       restaurant companies, consumer brands and top professional services       firms, including Anheuser-Busch, McDonald\u2019s, Accenture and Subway.</li><li>PZZA  <font color=\"green\">+1.03%</font> premarket to  $51.00.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17458327-papa-john-s-appoints-karlin-linhardt-global-chief-marketing-officer\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446465\" data-linked=\"Papa John&#39;s appoints new CMO\" data-tweet=\"$PZZA - Papa John&#39;s appoints new CMO https://seekingalpha.com/news/3446465-papa-johns-appoints-new-cmo?source=tweet\" data-url=\"https://seekingalpha.com/news/3446465-papa-johns-appoints-new-cmo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446463\" data-ts=\"1553778430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446463-therapix-bio-down-18-on-pricing-registered-direct-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapix Bio down 18% on pricing registered direct offering</a></h4><ul> <li>Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences Ltd.'>TRPX</a>) has <a href=\"https://seekingalpha.com/pr/17458246-therapix-biosciences-announces-pricing-2_25-million-registered-direct-offering\" target=\"_blank\">entered</a> into definitive agreements with several institutional investors providing for the issuance of an aggregate of 642,853 ADS at a price of $3.50/ADS in a registered direct offering.</li><li>Additionally, in a concurrent private placement, the Company will issue warrants to purchase up to 482,139 ADSs. The warrants will have a term of 3 years, with an exercise price of $3.50/ADS.</li>                  <li>Expected gross proceeds are ~$2.25M. Net proceeds will be used for general corporate, product development purposes and the repayment of a portion of outstanding debt.</li> <li>Closing date is April 1.</li><li>Shares are down <font color=\"red\">18%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446463\" data-linked=\"Therapix Bio down 18% on pricing registered direct offering\" data-tweet=\"$TRPX - Therapix Bio down 18% on pricing registered direct offering https://seekingalpha.com/news/3446463-therapix-bio-down-18-on-pricing-registered-direct-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3446463-therapix-bio-down-18-on-pricing-registered-direct-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446457\" data-ts=\"1553777970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446457-facebook-charged-fair-housing-act-violations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook charged with Fair Housing Act violations</a></h4><ul><li>The U.S. Department of Housing and Urban Development charges Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook, Inc.'>FB</a>) with Fair Housing Act violations <a href=\"https://in.reuters.com/article/facebook-advertisers/facebook-charged-with-racial-discrimination-in-targeted-housing-ads-idINKCN1R91GY?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FINbusinessNews+%28News+%2F+IN+%2F+Business+News%29\" target=\"_blank\">accusing</a> the company's targeted ads of race and color discrimination.</li><li>HUD says Facebook's housing-related ads also restricted viewers according to religion, sex, disability, and national origin.</li><li>Facebook says it has been working with HUD to address the concerns, took action to prevent ad discrimination, and is surprised by HUD's decision.</li><li>FB shares are <font color=\"red\">down 1.2%</font> pre-market to $163.90.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3444175-facebook-apologizes-blocking-wh-aide-settles-discrimination-suits\" target=\"_blank\">Facebook apologizes for blocking WH aide; settles discrimination suits</a> (March 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446457\" data-linked=\"Facebook charged with Fair Housing Act violations\" data-tweet=\"$FB - Facebook charged with Fair Housing Act violations https://seekingalpha.com/news/3446457-facebook-charged-fair-housing-act-violations?source=tweet\" data-url=\"https://seekingalpha.com/news/3446457-facebook-charged-fair-housing-act-violations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}